Professor David G Kiely

All publications

Journal articles

• Smith H, Thompson AAR, Akil M, Alabed S, Charalampopoulos A, Dwivedi K, Elliot CA, Hameed A, Haque A, Hamilton N , Hill C et al (2024) The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registry. The Journal of Heart and Lung Transplantation, 43(10), 1629-1639. View this article in WRRO
• Tello K, Yogeswaran A, Majeed RW, Kiely DG, Lawrie A, Brittain E, Annis JS, Olschewski H, Kovacs G, Hassoun PM , Balasubramanian A et al (2024) Phosphodiesterase-5 Inhibitor Treatment is Associated with Improved Survival in Pulmonary Hypertension Associated with COPD in the PVRI GoDeep Meta-Registry. CHEST.
• Cauchi M, Mills AR, Lawrie A, Kiely DG & Kadirkamanathan V (2024) Individualized survival predictions using state space model with longitudinal and survival data. Journal of The Royal Society Interface, 21(216). View this article in WRRO
• Lawrie A, Hamilton N, Wood S, Exposto F, Muzwidzwa R, Raiteri L, Beaudet A, Muller A, Sauter R, Pillai N & Kiely DG (2024) Association of risk assessment at diagnosis with healthcare resource utilization and health‐related quality of life outcomes in pulmonary arterial hypertension. Pulmonary Circulation, 14(3).
• Lawrie A, Chin K, Fong Y, Gargano C, Gitton X, He C, Kiely DG, Zhou L, Zhou L, Maron BA , Quinn D et al (2024) Two prospective, multicenter studies for the identification of biomarker signatures for early detection of pulmonary hypertension (PH): The CIPHER and CIPHER‐MRI studies. Pulmonary Circulation, 14(2).
• Abdulaal L, Maiter A, Salehi M, Sharkey M, Alnasser T, Garg P, Rajaram S, Hill C, Johns C, Rothman AMK , Dwivedi K et al (2024) A systematic review of artificial intelligence tools for chronic pulmonary embolism on CT pulmonary angiography. Frontiers in Radiology, 4, 1335349.
• Yogeswaran A, Gall H, Fünderich M, Wilkins MR, Howard L, Kiely DG, Lawrie A, Hassoun PM, Sirenklo Y, Torbas O , Sweatt AJ et al (2024) Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension. CHEST.
• Varian F, Dick J, Battersby C, Roman S, Ablott J, Watson L, Binmahfooz S, Zafar H, Colgan G, Cannon J , Suntharalingam J et al (2024) Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14(1).
• Dwivedi K, Sharkey M, Delaney L, Alabed S, Rajaram S, Hill C, Johns C, Rothman A, Mamalakis M, Thompson AAR , Wild J et al (2024) Improving Prognostication in Pulmonary Hypertension Using AI-quantified Fibrosis and Radiologic Severity Scoring at Baseline CT. Radiology, 310(2).
• Torbicki A, Channick R, Galiè N, Kiely DG, Moceri P, Peacock A, Swift AJ, Tawakol A, Vonk Noordegraaf A, Flores D , Martin N et al (2024) Effect of macitentan in pulmonary arterial hypertension and the relationship between echocardiography and cMRI variables: REPAIR echocardiography sub-study results. Cardiology and Therapy. View this article in WRRO
• Kiely DG, Channick R, Flores D, Galiè N, MacDonald G, Marcus JT, Mitchell L, Peacock A, Rosenkranz S, Tawakol A , Torbicki A et al (2024) Comparison of cardiac magnetic resonance imaging, functional and haemodynamic variables in pulmonary arterial hypertension: insights from REPAIR. ERJ Open Research, 10(1), 00547-2023.
• Ulrich A, Wu Y, Draisma H, Wharton J, Swietlik EM, Cebola I, Vasilaki E, Balkhiyarova Z, Jarvelin M-R, Auvinen J , Herzig K-H et al (2024) Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension. Nature Communications, 15(1). View this article in WRRO
• Kiely DG, Hamilton N, Wood S, Durrington C, Exposto F, Muzwidzwa R, Raiteri L, Beaudet A, Muller A, Sauter R , Pillai N et al (2024) Risk assessment and real-world outcomes in chronic thromboembolic pulmonary hypertension: insights from a UK pulmonary hypertension referral service. BMJ Open, 14(1), e080068-e080068.
• Correa-Jaque P, Lin Y, Lin S, Liu Y, Fauvel C, Vanderpool R, Kanwar M, Kraisangka J, Perer A, Everett AD , Alabed S et al (2023) Abstract 13918: Improvement of Pulmonary Arterial Hypertension (PAH) Risk Assessment Model Using Cardiac Magnetic Resonance Imaging Variables. Circulation, 148(Suppl_1).
• Moher Alsady T, Voskrebenzev A, Behrendt L, Olsson K, Heußel CP, Gruenig E, Gall H, Ghofrani A, Roller F, Harth S , Marshall H et al (2023) Multicenter standardization of phase-resolved functional lung MRI in patients with suspected chronic thromboembolic pulmonary hypertension. Journal of Magnetic Resonance Imaging. View this article in WRRO
• Olsson KM, Corte TJ, Kamp JC, Montani D, Nathan SD, Neubert L, Price LC & Kiely DG (2023) Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management. The Lancet Respiratory Medicine, 11(9), 820-835.
• Welch CL, Aldred MA, Balachandar S, Dooijes D, Eichstaedt CA, Gräf S, Houweling AC, Machado RD, Pandya D, Prapa M , Shaukat M et al (2023) Defining the clinical validity of genes reported to cause pulmonary arterial hypertension. Genetics in Medicine, 25(11), 100925-100925.
• Hameed A, Condliffe R, Swift AJ, Alabed S, Kiely DG & Charalampopoulos A (2023) Assessment of Right Ventricular Function—a State of the Art. Current Heart Failure Reports, 20(3), 194-207.
• Alkhanfar D, Dwivedi K, Alandejani F, Shahin Y, Alabed S, Johns C, Garg P, Thompson AAR, Rothman AMK, Hameed A , Charalampopoulos A et al (2023) Non-invasive detection of severe PH in lung disease using magnetic resonance imaging. Frontiers in Cardiovascular Medicine, 10.
• Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P , Ferreira DS et al (2023) 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Giornale italiano di cardiologia (2006), 24(4), 1e-116e.
• Zhong L, Leng S, Alabed S, Chai P, Teo L, Ruan W, Low T-T, Wild JM, Allen JC, Lim ST , Tan JL et al (2023) Pulmonary Artery Strain Predicts Prognosis in Pulmonary Arterial Hypertension. JACC: Cardiovascular Imaging.
• Mamalakis M, Dwivedi K, Sharkey M, Alabed S, Kiely D & Swift AJ (2023) A transparent artificial intelligence framework to assess lung disease in pulmonary hypertension. Scientific Reports, 13.
• (2023) Corrigendum to: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). European Heart Journal, 44(15), 1312-1312.
• Macdonald A, Salehi M, Alabed S, Maiter A, Goh ZM, Dwivedi K, Johns C, Cogliano M, Alandejani F, Condliffe R , Wild JM et al (2023) Semi-automatic thresholding of RV trabeculation improves repeatability and diagnostic value in suspected pulmonary hypertension. Frontiers in Cardiovascular Medicine, 9.
• Eichstaedt CA, Belge C, Chung WK, Gräf S, Grünig E, Montani D, Quarck R, Tenorio-Castano JA, Soubrier F, Trembath RC & Morrell NW (2023) Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH. European Respiratory Journal, 61(2), 2201471-2201471.
• Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P , Ferreira DS et al (2023) 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Respiratory Journal, 61(1), 2200879-2200879.
• Shahin Y, Tschirren J, Kiely D & Swift AJ (2022) Abstract 14089: CT Analysis of Small Pulmonary Vessels and Its Association With Pulmonary Function Tests and Prognosis in Pulmonary Hypertension. Circulation, 146(Suppl_1).
• Hoeper MM, Vonk-Noordegraaf A & Kiely DG (2022) Phenotypes of idiopathic pulmonary arterial hypertension – Authors' reply. The Lancet Respiratory Medicine, 10(10), e90-e91.
• Lawrie A, Hamilton N, Wood S, Exposto F, Muzwidzwa R, Raiteri L, Beaudet A, Muller A, Sauter R, Pillai N & Kiely DG (2022) Healthcare resource utilization and quality of life in patients with sarcoidosis‐associated pulmonary hypertension. Pulmonary Circulation, 12(4).
• Sammut MA, Condliffe R, Elliot C, Hameed A, Lewis R, Kiely DG, Kyriacou A, Middleton JT, Raithatha A, Rothman A , Thompson AAR et al (2022) Atrial flutter and fibrillation in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension in the ASPIRE registry: Comparison of rate versus rhythm control approaches. International Journal of Cardiology.
• Alabed S, Alandejani F, Dwivedi K, Karunasaagarar K, Sharkey M, Garg P, de Koning PJH, Tóth A, Shahin Y, Johns C , Mamalakis M et al (2022) Validation of Artificial Intelligence Cardiac MRI Measurements: Relationship to Heart Catheterization and Mortality Prediction. Radiology, 304(3), E56-E56.
• Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P , Ferreira DS et al (2022) 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal, 43(38), 3618-3731.
• Majeed RW, Wilkins MR, Howard L, Hassoun PM, Anthi A, Cajigas HR, Cannon J, Chan SY, Damonte V, Elwing J , Förster K et al (2022) Pulmonary Vascular Research Institute GoDeep: a meta-registry merging deep phenotyping datafrom international PH reference centers. Pulmonary Circulation, 12(3). View this article in WRRO
• Boehm M, Arnold N, Braithwaite A, Pickworth J, Lu C, Novoyatleva T, Kiely DG, Grimminger F, Ghofrani HA, Weissmann N , Seeger W et al (2022) Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension. BMC Pulmonary Medicine, 22(1).
• Prapa M, Lago-Docampo M, Swietlik EM, Montani D, Eyries M, Humbert M, Welch CCL, Chung W, Berger RMF, Bogaard HJ , Danhaive O et al (2022) First genotype-phenotype study in TBX4 syndrome : gain-of-function mutations causative for lung disease. American Journal of Respiratory and Critical Care Medicine.
• Jones RJ, De Bie EMDD, Groves E, Zalewska KI, Swietlik EM, Treacy CM, Martin JM, Polwarth G, Li W, Guo J , Baxendale HE et al (2022) Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine, 206(1), 81-93.
• Hoeper MM, Dwivedi K, Pausch C, Lewis RA, Olsson KM, Huscher D, Pittrow D, Grünig E, Staehler G, Vizza CD , Gall H et al (2022) Phenotyping of idiopathic pulmonary arterial hypertension : a registry analysis. The Lancet Respiratory Medicine. View this article in WRRO
• Harbaum L, Rhodes CJ, Wharton J, Lawrie A, Karnes JH, Desai AA, Nichols WC, Humbert M, Montani D, Girerd B , Sitbon O et al (2022) Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine, 205(12), 1449-1460.
• Alabed S, Alandejani F, Dwivedi K, Karunasaagarar K, Sharkey M, Garg P, de Koning PJH, Tóth A, Shahin Y, Johns C , Mamalakis M et al (2022) Validation of Artificial Intelligence Cardiac MRI Measurements: Relationship to Heart Catheterization and Mortality Prediction.. Radiology, 212929.
• Goh ZM, Balasubramanian N, Alabed S, Dwivedi K, Shahin Y, Rothman AMK, Garg P, Lawrie A, Capener D, Thompson AAR , Alandejani F et al (2022) Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response.. Heart. View this article in WRRO
• Garg P, Gosling R, Swoboda P, Jones R, Rothman A, Wild JM, Kiely DG, Condliffe R, Alabed S & Swift AJ (2022) Cardiac magnetic resonance identifies raised left ventricular filling pressure: prognostic implications. European Heart Journal. View this article in WRRO
• Alabed S, Uthoff J, Zhou S, Garg P, Dwivedi K, Alandejani F, Gosling R, Schobs L, Brook M, Capener D , Johns C et al (2022) Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension. European Heart Journal - Digital Health, 3(2), 265-275.
• Achini‐Gutzwiller FR, Snowden JA, Corbacioglu S, Greco R, Greco R, Alexander T, Snowden J, Badoglio M, Labopin M, Abinun M , Apte S et al (2022) Haematopoietic stem cell transplantation for severe autoimmune diseases in children : a review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation. British Journal of Haematology, 198(1), 24-45.
• Rawlings GH, Beail N, Condliffe R, Kiely DG, Thompson AR, Sabroe I & Armstrong I (2022) Examining the impact of pulmonary hypertension on nonprofessional caregivers: A mixed‐methods systematic review. Pulmonary Circulation, 12(2).
• Alandejani F, Alabed S, Garg P, Goh ZM, Karunasaagarar K, Sharkey M, Salehi M, Aldabbagh Z, Dwivedi K, Mamalakis M , Metherall P et al (2022) Training and clinical testing of artificial intelligence derived right atrial cardiovascular magnetic resonance measurements. Journal of Cardiovascular Magnetic Resonance, 24(1).
• Alandejani F, Hameed A, Tubman E, Alabed S, Shahin Y, Lewis RA, Dwivedi K, Mahmood A, Middleton J, Watson L , Alkhanfar D et al (2022) Imaging and risk stratification in pulmonary arterial hypertension : time to include right ventricular assessment. Frontiers in Cardiovascular Medicine, 9. View this article in WRRO
• Hatano M, Abe K, Koike G, Takahashi T, Tunmer G & Kiely DG (2022) Positive Predictors for Response to Ambrisentan Combination Therapy in Pulmonary Arterial Hypertension. International Heart Journal, 63(1), 99-105.
• Dwivedi K, Condliffe R, Sharkey M, Lewis R, Alabed S, Rajaram S, Hill C, Saunders L, Metherall P, Alandejani F , Alkhanfar D et al (2022) Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease.. ERJ Open Res, 8(1).
• Howard LSGE, He J, Watson GMJ, Huang L, Wharton J, Luo Q, Kiely DG, Condliffe R, Pepke-Zaba J, Morrell NW , Sheares KK et al (2022) Supplementation with Iron in Pulmonary Arterial Hypertension: Two Randomized Crossover Trials (vol 18, pg 981, 2021). ANNALS OF THE AMERICAN THORACIC SOCIETY, 19(4), 703-703.
• Kariotis S, Jammeh E, Swietlik EM, Pickworth JA, Rhodes CJ, Otero P, Wharton J, Iremonger J, Dunning MJ, Pandya D , Mascarenhas TS et al (2021) Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood. Nature Communications, 12. View this article in WRRO
• Vonk Noordegraaf A, Channick R, Cottreel E, Kiely DG, Marcus JT, Martin N, Moiseeva O, Peacock A, Swift AJ, Tawakol A , Torbicki A et al (2021) The REPAIR Study : effects of macitentan on RV structure and function in pulmonary arterial hypertension. JACC: Cardiovascular Imaging.
• Swift AJ, Wilson F, Cogliano M, Kendall L, Alandejani F, Alabed S, Hughes P, Shahin Y, Saunders L, Oram C , Capener D et al (2021) Repeatability and sensitivity to change of non-invasive end points in PAH: the RESPIRE study. Thorax, 76(10), 1032-1035.
• Wilkins MR, Mckie MA, Law M, Roussakis AA, Harbaum L, Church C, Coghlan JG, Condliffe R, Howard LS, Kiely DG , Lordan J et al (2021) Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single-arm efficacy. Pulmonary Circulation, 11(4). View this article in WRRO
• Toshner M, Church C, Harbaum L, Rhodes C, Villar Moreschi SS, Liley J, Jones R, Arora A, Batai K, Desai AA , Coghlan JG et al (2021) Mendelian randomisation and experimental medicine approaches to IL-6 as a drug target in PAH.. Eur Respir J.
• Haque A, Kiely DG, Kovacs G, Thompson AAR & Condliffe R (2021) Pulmonary hypertension phenotypes in patients with systemic sclerosis. European Respiratory Review, 30(161), 210053-210053.
• Kiely DG & Condliffe R (2021) Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow. European Respiratory Journal, 58(2), 2102008-2102008.
• Alabed S, Karunasaagarar K, Alandejani F, Garg P, Uthoff J, Metherall P, Sharkey M, Lu H, Wild JM, Kiely DG , Van Der Geest RJ et al (2021) High interstudy repeatability of automatic deep learnt biventricular CMR measurements. European Heart Journal - Cardiovascular Imaging, 22(Supplement_2).
• Alabed S, Karunasaagarar K, Alandejani F, Garg P, Uthoff J, Metherall P, Sharkey M, Lu H, Wild JM, Kiely DG , Van Der Geest RJ et al (2021) Fully automated CMR derived stroke volume correlates with right heart catheter measurements in patients with suspected pulmonary hypertension. European Heart Journal - Cardiovascular Imaging, 22(Supplement_2).
• Errington N, Iremonger J, Pickworth JA, Kariotis S, Rhodes CJ, Rothman AMK, Condliffe R, Elliot CA, Kiely DG, Howard LS , Wharton J et al (2021) A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach. EBioMedicine, 69. View this article in WRRO
• Guth S, D'Armini AM, Delcroix M, Nakayama K, Fadel E, Hoole SP, Jenkins DP, Kiely DG, Kim NH, Lang IM , Madani MM et al (2021) Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry. ERJ Open Research, 7(3), 00850-2020.
• Goh ZM, Alabed S, Shahin Y, Rothman AMK, Garg P, Lawrie A, Capener D, Thompson AAR, Alandejani FAA, Johns CS , Lewis RA et al (2021) Right ventricular adaptation assessed using cardiac magnetic resonance predicts survival in pulmonary arterial hypertension. JACC: Cardiovascular Imaging, 14(6), 1271-1272. View this article in WRRO
• Garg P, Lewis RA, Johns CS, Swift AJ, Capener D, Rajaram S, Thompson AAR, Condliffe R, Elliot CA, Charalampopoulos A , Hameed AG et al (2021) Cardiovascular magnetic resonance predicts all-cause mortality in pulmonary hypertension associated with heart failure with preserved ejection fraction. International Journal of Cardiovascular Imaging. View this article in WRRO
• Zhu N, Swietlik EM, Welch CL, Pauciulo MW, Hagen JJ, Zhou X, Guo Y, Karten J, Pandya D, Tilly T , Lutz KA et al (2021) Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH. Genome Medicine, 13(1), 80-80. View this article in WRRO
• Boam T, Kiely D, Peeraully R, Jancauskaite M & Fraser N (2021) Outcomes following emergency fixation of torted and non-torted testes. Journal of Pediatric Urology.
• Kiely DG, Channick R, Flores D, Galiè N, Marcus JT, Peacock A, Rosenkranz S, Tawakol A, Torbicki A, Noordegraaf AV , Wetherill G et al (2021) COMPARISON OF STANDARDIZED TREATMENT EFFECT SIZES FOR INVASIVE AND NON-INVASIVE ENDPOINTS IN PULMONARY ARTERIAL HYPERTENSION: INSIGHTS FROM THE REPAIR STUDY. Journal of the American College of Cardiology, 77(18), 1672-1672.
• Dwivedi K, Sharkey M, Condliffe R, Uthoff JM, Alabed S, Metherall P, Lu H, Wild JM, Hoffman EA, Swift AJ & Kiely DG (2021) Pulmonary hypertension in association with lung disease : quantitative CT and artificial intelligence to the rescue? State-of-the-art review. Diagnostics, 11(4). View this article in WRRO
• Alabed S, Shahin Y, Garg P, Alandejani F, Johns CS, Lewis RA, Condliffe R, Wild JM, Kiely DG & Swift AJ (2021) Correction. JACC: Cardiovascular Imaging, 14(4), 884-884.
• Howard LSGE, He J, Watson GMJ, Huang L, Wharton J, Luo Q, Kiely DG, Condliffe R, Pepke-Zaba J, Morrell NW , Sheares KK et al (2021) Supplementation with iron in pulmonary arterial hypertension : two randomized crossover trials. Annals of the American Thoracic Society.
• Alabed S, Saunders L, Garg P, Shahin Y, Alandejani F, Rolf A, Puntmann VO, Nagel E, Wild JM, Kiely DG & Swift AJ (2021) Myocardial T1-mapping and extracellular volume in pulmonary arterial hypertension: A systematic review and meta-analysis. Magnetic Resonance Imaging, 79, 66-75.
• Price LC, Martinez G, Brame A, Pickworth T, Samaranayake C, Alexander D, Garfield B, Aw T-C, McCabe C, Mukherjee B , Harries C et al (2021) Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement. British Journal of Anaesthesia.
• Swift AJ, Lu H, Uthoff J, Garg P, Cogliano M, Taylor J, Metherall P, Zhou S, Johns CS, Alabed S , Condliffe RA et al (2021) A machine learning cardiac magnetic resonance approach to extract disease features and automate pulmonary arterial hypertension diagnosis. European Heart Journal - Cardiovascular Imaging, 22(2), 236-245. View this article in WRRO
• Swietlik EM, Greene D, Zhu N, Megy K, Cogliano M, Rajaram S, Pandya D, Tilly T, Lutz KA, Welch CCL , Pauciulo MW et al (2021) Bayesian inference associates rare KDR variants with specific phenotypes in pulmonary arterial hypertension. Circulation: Genomic and Precision Medicine, 14(1), 57-70. View this article in WRRO
• Sommer N, Ghofrani A, Pak O, Bonnet S, Provencher S, Sitbon O, Rosenkranz S, Hoeper MM & Kiely DG (2021) Current and future treatments of pulmonary arterial hypertension. British Journal of Pharmacology, 178(1), 6-30. View this article in WRRO
• Alabed S, Garg P, Johns CS, Alandejani F, Shahin Y, Dwivedi K, Zafar H, Wild JM, Kiely DG & Swift AJ (2020) Cardiac Magnetic Resonance in Pulmonary Hypertension—an Update. Current Cardiovascular Imaging Reports, 13(12).
• Rawlings GH, Beail N, Armstrong I, Condliffe R, Kiely DG, Sabroe I & Thompson AR (2020) Adults’ experiences of living with pulmonary hypertension: a thematic synthesis of qualitative studies. BMJ Open, 10(12). View this article in WRRO
• Condliffe R, Kiely DG & Lewis RA (2020) Mild parenchymal lung disease is still lung disease. The European respiratory journal, 56(5).
• Rosenkranz S, Channick R, Cottreel E, Galie N, Kiely DG, Marcus JT, Swift AJ, Tawakol A, Torbicki A, Vonk Noordegraaf A , Wetherill G et al (2020) Effect of macitentan on left ventricular (LV) function in pulmonary arterial hypertension (PAH): results from REPAIR. European Heart Journal, 41(Supplement_2).
• Alabed S, Shahin Y, Garg P, Alandejani F, Johns CS, Lewis RA, Condliffe R, Wild JM, Kiely DG & Swift AJ (2020) Cardiac-MRI predicts clinical worsening and mortality in pulmonary arterial hypertension: a systematic review and meta-analysis. JACC: Cardiovascular Imaging. View this article in WRRO
• Lewis RA, Billings CG, Hurdman JA, Smith IA, Austin M, Armstrong IJ, Middleton J, Rothman AMK, Harrington J, Hamilton N , Hameed AG et al (2020) Maximal exercise testing using the incremental shuttle walking test can be used to risk stratify patients with pulmonary arterial hypertension. Annals of the American Thoracic Society. View this article in WRRO
• Swift AJ, Dwivedi K, Johns C, Garg P, Chin M, Currie BJ, Rothman AMK, Capener D, Shahin Y, Elliot CA , Charalampopolous T et al (2020) Diagnostic accuracy of CT pulmonary angiography in suspected pulmonary hypertension. European Radiology, 30(9), 4918-4929. View this article in WRRO
• Sofianopoulou E, Church C, Coghlan G, Howard L, Johnson M, Kiely DG, Lawrie A, Lordan J, Wilkins MR, Wort SJ , Morrell NW et al (2020) Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?. European Respiratory Journal, 56(2).
• Omura J, Habbout K, Shimauchi T, Wu W-H, Breuils-Bonnet S, Tremblay E, Martineau S, Nadeau V, Gagnon K, Mazoyer F , Perron J et al (2020) Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension. Circulation, 142(15), 1464-1484.
• Thaventhiran JED, Lango Allen H, Burren OS, Rae W, Greene D, Staples E, Zhang Z, Farmery JHR, Simeoni I, Rivers E , Maimaris J et al (2020) Publisher Correction: Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature, 584(7819), E2-E2.
• Lewis RA, Armstrong I, Bergbaum C, Brewis MJ, Cannon J, Charalampopoulos A, Church AC, Coghlan JG, Davies RJ, Dimopoulos K , Elliot C et al (2020) EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multi-centre study. European Respiratory Journal. View this article in WRRO
• Lewis RA, Durrington C, Condliffe R & Kiely DG (2020) BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?. European Respiratory Review, 29(156). View this article in WRRO
• Barker N, Zafar H, Fidock B, Elhawaz A, Al-Mohammad A, Rothman A, Kiely DG, van der Geest RJ, Westenberg J, Swift AJ , Wild JM et al (2020) Age-associated changes in 4D flow CMR derived tricuspid valvular flow and right ventricular blood flow kinetic energy. Scientific Reports, 10(1). View this article in WRRO
• Lewis RA, Thompson AAR, Billings CG, Charalampopoulos A, Elliot CA, Hamilton N, Hill C, Hurdman J, Rajaram S, Sabroe I , Swift AJ et al (2020) Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension. European Respiratory Journal, 55(6). View this article in WRRO
• Thaventhiran JED, Lango Allen H, Burren OS, Rae W, Greene D, Staples E, Zhang Z, Farmery JHR, Simeoni I, Rivers E , Maimaris J et al (2020) Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature. View this article in WRRO
• Rhodes CJ, Otero-Núñez P, Wharton J, Swietlik EM, Kariotis S, Harbaum L, Dunning MJ, Elinoff JM, Errington N, Thomson AAR , Iremonger J et al (2020) Whole blood RNA profiles associated with pulmonary arterial hypertension and clinical outcome. American Journal of Respiratory and Critical Care Medicine. View this article in WRRO
• Rothman A, Kiely D, Vachiery J-L, Howard LS, MIkhail GW, Lang IM, Jonas M, Shav D, Shabtay O, Avriel A , Lewis GD et al (2020) Intravascular ultrasound pulmonary artery denervation to treat pulmonary arterial hypertension (TROPHY1): multicenter, early feasibility study. JACC: Cardiovascular Interventions, 13(8), 989-999. View this article in WRRO
• Lasch F, Karch A, Koch A, Derlin T, Voskrebenzev A, Alsady TM, Hoeper MM, Gall H, Roller F, Harth S , Steiner D et al (2020) Comparison of MRI and VQ-SPECT as a Screening Test for Patients With Suspected CTEPH: CHANGE-MRI Study Design and Rationale. Frontiers in Cardiovascular Medicine, 7. View this article in WRRO
• Lewis RA, Billings CG, Bolger A, Bowater S, Charalampopoulos A, Clift P, Elliot CA, English K, Hamilton N, Hill C , Hurdman J et al (2020) Partial anomalous pulmonary venous drainage in patients presenting with suspected pulmonary hypertension: A series of 90 patients from the ASPIRE registry. Respirology. View this article in WRRO
• Noordegraaf AV, Channick R, Cottreel E, Kiely D, Martin N, Moiseeva O, Peacock A, Tawakol A, Torbicki A, Rosenkranz S & Galiè N (2020) Results from the REPAIR Study Final Analysis: Effects of Macitentan on Right Ventricular (RV) Remodelling in Pulmonary Arterial Hypertension (PAH). The Journal of Heart and Lung Transplantation, 39(4), S16-S17.
• White RJ, Jerjes-Sanchez C, Bohns Meyer GM, Pulido T, Sepulveda P, Wang KY, Grünig E, Hiremath S, Yu Z, Gangcheng Z , Yip WLJ et al (2020) Combination therapy with oral treprostinil for pulmonary arterial hypertension. A double-blind placebo-controlled clinical trial. American Journal of Respiratory and Critical Care Medicine, 201(6), 707-717. View this article in WRRO
• Peacock AJ, Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JSR, Howard LS, Pepke-Zaba J, Sheares KKK , Corris PA et al (2020) Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?. Pulmonary Circulation, 10(1), 204589402091485-204589402091485.
• Lewis RA, Johns CS, Cogliano M, Capener D, Tubman E, Elliot CA, Charalampopoulos A, Sabroe I, Thompson AAR, Billings CG , Hamilton N et al (2020) Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine, 201(4), 458-468. View this article in WRRO
• Turro E, Astle WJ, Megy K, Gräf S, Greene D, Shamardina O, Allen HL, Sanchis-Juan A, Frontini M, Thys C , Stephens J et al (2020) Whole-genome sequencing of patients with rare diseases in a national health system. Nature, 583(7814), 96-102.
• Hodgson J, Swietlik EM, Salmon RM, Hadinnapola C, Nikolic I, Wharton J, Guo J, Liley J, Haimel M, Bleda M , Southgate L et al (2020) Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine, 201(5), 575-585.
• Bunclark K, Newnham M, Chiu Y, Ruggiero A, Villar SS, Cannon JE, Coghlan G, Corris PA, Howard L, Jenkins D , Johnson M et al (2020) A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension. Journal of Thrombosis and Haemostasis, 18(1), 114-122.
• Kiely DG, Lawrie A & Humbert M (2019) Screening strategies for pulmonary arterial hypertension. European Heart Journal Supplements, 21(Supplement_K), K9-K20. View this article in WRRO
• Armstrong I, Billings C, Kiely DG, Yorke J, Harries C, Clayton S & Gin-Sing W (2019) The patient experience of pulmonary hypertension : a large cross-sectional study of UK patients. BMC Pulmonary Medicine, 19(1). View this article in WRRO
• Arnold ND, Pickworth JA, West LE, Dawson S, Carvalho JA, Casbolt H, Braithwaite AT, Iremonger J, Renshall L, Germaschewski V , McCourt M et al (2019) A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension. Nature Communications, 10(1). View this article in WRRO
• Kiely DG, Doyle O, Drage E, Jenner H, Salvatelli V, Daniels FA, Rigg J, Schmitt C, Samyshkin Y, Lawrie A & Bergemann R (2019) Utilising artificial intelligence to determine patients at risk of a rare disease : idiopathic pulmonary arterial hypertension. Pulmonary Circulation, 9(4). View this article in WRRO
• Keen C, Hashmi-Greenwood M, York J, Armstrong IJ, Sage K & Kiely D (2019) Exploring a physiotherapy well-being review to deliver community-based rehabilitation in patients with pulmonary hypertension. Pulmonary Circulation, 9(4). View this article in WRRO
• Shahin Y, Johns C, Karunasaagarar K, Kiely DG & Swift AJ (2019) IodiNe Subtraction mapping in the diagnosis of Pulmonary chronIc thRomboEmbolic disease (INSPIRE) : rationale and methodology of a cross-sectional observational diagnostic study. Contemporary Clinical Trials Communications, 15. View this article in WRRO
• Middleton JT, Maulik A, Lewis R, Kiely DG, Toshner M, Charalampopoulos A, Kyriacou A & Rothman A (2019) Arrhythmic burden and outcomes in pulmonary arterial hypertension. Frontiers in Medicine, 6. View this article in WRRO
• Kiely D, Levin D, Hassoun P, Ivy DD, Jone P-N, Bwika J, Kawut SM, Lordan J, Lungu A, Mazurek J , Moledina S et al (2019) EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).. Pulmonary Circulation, 9(3). View this article in WRRO
• Wei W, Tuna S, Keogh MJ, Smith KR, Aitman TJ, Beales PL, Bennett DL, Gale DP, Bitner-Glindzicz MAK, Black GC , Brennan P et al (2019) Germline selection shapes human mitochondrial DNA diversity. Science, 364(6442), eaau6520-eaau6520.
• Gorman KM, Meyer E, Grozeva D, Spinelli E, McTague A, Sanchis-Juan A, Carss KJ, Bryant E, Reich A, Schneider AL , Pressler RM et al (2019) Bi-allelic Loss-of-Function CACNA1B Mutations in Progressive Epilepsy-Dyskinesia. The American Journal of Human Genetics, 104(5), 948-956.
• Billings CG, Lewis R, Hurdman JA, Condliffe R, Elliot C, Thompson AAR, Smith IA, Austin M, Armstrong IJ, Hamilton N , Charalampopoulos A et al (2019) The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry. Pulmonary Circulation, 9(2). View this article in WRRO
• Sofianopoulou E, Kaptoge S, Gräf S, Hadinnapola C, Treacy CM, Church C, Coghlan G, Gibbs JSR, Haimel M, Howard L , Johnson M et al (2019) Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: A United Kingdom cohort study analysis.. European Respiratory Journal. View this article in WRRO
• Barker N, Fidock B, Johns CS, Kaur H, Archer G, Rajaram S, Hill C, Thomas S, Karunasaagarar K, Capener D , Al-Mohammad A et al (2019) A Systematic Review of Right Ventricular Diastolic Assessment by 4D Flow CMR. BioMed Research International, 2019. View this article in WRRO
• Rhodes CJ, Batai K, Bleda M, Haimel M, Southgate L, Germain M, Pauciulo MW, Hadinnapola C, Aman J, Girerd B , Arora A et al (2019) Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis. The Lancet Respiratory Medicine, 7(3), 227-238. View this article in WRRO
• Condliffe R, Quadery SR, Jenkins DP, Armstrong IJ & Kiely DG (2019) Decision-making in pulmonary endarterectomy surgery. European Respiratory Journal, 53(1), 1801973-1801973.
• Grünig E, Eichstaedt C, Barberà J-A, Benjamin N, Blanco I, Bossone E, Cittadini A, Coghlan G, Corris P, D'Alto M , D'Andrea A et al (2019) ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension. European Respiratory Journal, 53(2), 1800332-1800332.
• Saunders L, Johns C, Stewart N, Oram C, Capener D, Puntmann V, Elliot C, Condliffe R, Kiely D, Wild JM , Graves M et al (2018) Diagnostic and prognostic significance of cardiovascular magnetic resonance native myocardial T1 mapping in patients with pulmonary hypertension. Journal of Cardiovascular Magnetic Resonance, 20. View this article in WRRO
• Farmery JHR, Smith ML & Lynch AG (2018) Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data. Scientific Reports, 8(1). View this article in WRRO
• Johns CS, Kiely DG, Rajaram S, Hill C, Thomas S, Karunasaagarar K, Garg P, Hamilton N, Solanki R, Capener DA , Elliot C et al (2018) Diagnosis of Pulmonary Hypertension with Cardiac MRI: Derivation and Validation of Regression Models.. Radiology, 290(1). View this article in WRRO
• Bohnen MS, Ma L, Zhu N, Qi H, McClenaghan C, Gonzaga-Jauregui C, Dewey FE, Overton JD, Reid JG, Shuldiner AR , Baras A et al (2018) Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension. Circulation. Genomic and precision medicine, 11(10). View this article in WRRO
• Johns CS, Wild JM, Rajaram S, Tubman E, Capener D, Elliot C, Condliffe R, Charalampopoulos A, Kiely DG & Swift AJ (2018) Identifying At-Risk Patients with Combined Pre- and Postcapillary Pulmonary Hypertension Using Interventricular Septal Angle at Cardiac MRI. Radiology, 289(1), 180120-180120. View this article in WRRO
• Quadery SR, Swift AJ, Billings C, Thompson AAR, Elliot CA, Hurdman J, Charalampopoulos A, Sabroe I, Armstrong I, Hamilton N , Sephton P et al (2018) The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension. European Respiratory Journal, 52(3), ---. View this article in WRRO
• Bergemann R, Allsopp J, Jenner H, Daniels FA, Drage E, Samyshkin Y, Schmitt C, Wood S, Kiely DG, Lawrie A & SPHInX Project team (2018) High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project.. Pulmonary Circulation, 8(4), 1-9. View this article in WRRO
• Johns CS, Kiely DG & Swift AJ (2018) Novel imaging techniques in pulmonary hypertension. Current Opinion in Cardiology, 33(6), 587-593.
• Snowden JA, Sharrack B, Akil M, Kiely DG, Lobo A, Kazmi M, Muraro PA & Lindsay JO (2018) Autologous haematopoietic stem cell transplantation (aHSCT) for severe resistant autoimmune and inflammatory diseases – a guide for the generalist. Clinical Medicine, 18(4), 329-334. View this article in WRRO
• Ito Y, Carss KJ, Duarte ST, Hartley T, Keren B, Kurian MA, Marey I, Charles P, Mendonça C, Nava C , Pfundt R et al (2018) De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures. The American Journal of Human Genetics, 103(1), 144-153. View this article in WRRO
• Whitworth J, Smith PS, Martin J-E, West H, Luchetti A, Rodger F, Clark G, Carss K, Stephens J, Stirrups K , Penkett C et al (2018) Comprehensive cancer-predisposition gene testing in an adult multiple primary tumor series shows a broad range of deleterious variants and atypical tumor phenotypes. The American Journal of Human Genetics, 103(1), 3-18. View this article in WRRO
• O’Riordan D, Kiely DG & O’Driscoll BR (2018) Reversible pulmonary artery perfusion abnormalities in the postpartum period as a precursor to the development of pulmonary arterial hypertension. Pulmonary Circulation, 8(3). View this article in WRRO
• Chin M, Johns C, Currie BJ, Weatherley N, Hill C, Elliot C, Rajaram S, Wild JM, Condliffe R, Bianchi S , Kiely DG et al (2018) Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility. Frontiers in Cardiovascular Medicine, 5. View this article in WRRO
• Charalampopoulos A, Lewis R, Hickey P, Durrington C, Elliot C, Condliffe R, Sabroe I & Kiely DG (2018) Pathophysiology and diagnosis of pulmonary hypertension due to left heart disease. Frontiers in Medicine, 5. View this article in WRRO
• Currie BJ, Johns C, Chin M, Charalampopolous T, Elliot CA, Garg P, Rajaram S, Hill C, Wild JW, Condliffe RA , Kiely DG et al (2018) CT derived left atrial size identifies left heart disease in suspected pulmonary hypertension: Derivation and validation of predictive thresholds. International Journal of Cardiology, 260, 172-177. View this article in WRRO
• Gräf S, Haimel M, Bleda M, Hadinnapola C, Southgate L, Li W, Hodgson J, Liu B, Salmon RM, Southwood M , Machado RD et al (2018) Identification of rare sequence variation underlying heritable pulmonary arterial hypertension. Nature Communications, 9(1). View this article in WRRO
• Kiely DG (2018) i069 Assessment and management of pulmonary vascular manifestations of systemic sclerosis. Rheumatology, 57(suppl_3).
• Kiely DG (2018) i091 When to screen patients for pulmonary hypertension and interpreting the results. Rheumatology, 57(suppl_3).
• Boehm M, Arnold N, Braithwaite A, Pickworth J, Lu C, Novoyatleva T, Kiely DG, Grimminger F, Ghofrani HA, Weissmann N , Seeger W et al (2018) Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension. BMC Pulmonary Medicine, 18(1). View this article in WRRO
• Johns CS, Wild JM, Rajaram S, Swift AJ & Kiely DG (2018) Current and emerging imaging techniques in the diagnosis and assessment of pulmonary hypertension. Expert Review of Respiratory Medicine, 12(2), 145-160. View this article in WRRO
• Yorke J, Deaton C, Campbell M, McGowen L, Sephton P, Kiely DG & Armstrong I (2018) Symptom severity and its effect on health-related quality of life over time in patients with pulmonary hypertension: a multisite longitudinal cohort study. BMJ Open Respiratory Research, 5(1), e000263-e000263. View this article in WRRO
• Shovlin CL, Condliffe R, Donaldson JW, Kiely DG & Wort SJ (2017) Pulmonary arteriovenous malformations emerge from the shadows. Thorax, 72(12), 1071-1073.
• Shovlin CL, Condliffe R, Donaldson JW, Kiely DG & Wort SJ (2017) British Thoracic Society Clinical Statement on Pulmonary Arteriovenous Malformations. Thorax, 72(12), 1154-1163.
• Hadinnapola C, Bleda M, Haimel M, Screaton N, Swift AJ, Dorfmüller P, Preston SD, Southwood M, Hernandez-Sanchez J, Martin J , Treacy C et al (2017) Phenotypic Characterisation of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically with Pulmonary Arterial Hypertension.. Circulation, 136(21), 2022-2033. View this article in WRRO
• Johns CS, Swift AJ, Rajaram S, Hughes PJC, Capener DJ, Kiely DG & Wild JM (2017) Lung perfusion: MRI vs. SPECT for screening in suspected chronic thromboembolic pulmonary hypertension. Journal of Magnetic Resonance Imaging, 46(6), 1693-1697. View this article in WRRO
• Michelakis ED, Gurtu V, Webster L, Barnes G, Watson G, Howard L, Cupitt J, Paterson I, Thompson RB, Chow K , O'Regan DP et al (2017) Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.. Sci Transl Med, 9(413).
• van Baalen S, Carusi A, Sabroe I & Kiely DG (2017) A social‐technological epistemology of clinical decision‐making as mediated by imaging. Journal of Evaluation in Clinical Practice, 23(5), 949-958. View this article in WRRO
• Price LC, Dimopoulos K, Marino P, Alonso-Gonzalez R, McCabe C, Kemnpy A, Swan L, Boutsikou M, Al Zahrani A, Coghlan GJ , Schreiber BE et al (2017) The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension. Thorax, 72(11), 1035-1045.
• Rhodes CJ, Wharton J, Ghataorhe P, Watson G, Girerd B, Howard LS, Gibbs JSR, Condliffe R, Elliot CA, Kiely DG , Simonneau G et al (2017) Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study. The Lancet Respiratory Medicine, 5(9), 717-726. View this article in WRRO
• Johns CS, Wild J, Rajaram S, Kiely D & Swift A (2017) Septal angle on MRI predicts combined pre- and post-capillary pulmonary hypertension. Clinical Radiology, 72, S1-S2.
• Swift AJ, Capener D, Johns C, Hamilton N, Rothman A, Elliot C, Condliffe R, Charalampopoulos A, Rajaram S, Lawrie A , Campbell MJ et al (2017) Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine, 196(2). View this article in WRRO
• Condliffe R & Kiely DG (2017) Critical care management of pulmonary hypertension. BJA Education, 17(7), 228-234.
• Khan KN, El-Asrag ME, Ku CA, Holder GE, McKibbin M, Arno G, Poulter JA, Carss K, Bommireddy T, Bagheri S , Bakall B et al (2017) Specific Alleles of CLN7/MFSD8, a Protein That Localizes to Photoreceptor Synaptic Terminals, Cause a Spectrum of Nonsyndromic Retinal Dystrophy. Investigative Opthalmology & Visual Science, 58(7), 2906-2906.
• Goddard J, Armstrong I, Kiely D, Elliot C, Charalampopoulos A, Condliffe R, Stone B & Sabroe I (2017) Combining creative writing and narrative analysis to deliver new insights into the impact of pulmonary hypertension. BMJ Open Respiratory Research, 4(1). View this article in WRRO
• Farge D, Burt RK, Oliveira M-C, Mousseaux E, Rovira M, Marjanovic Z, de Vries-Bouwstra J, Del Papa N, Saccardi R, Shah SJ , Lee DC et al (2017) Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners.. Bone Marrow Transplantation. View this article in WRRO
• Billings CG, Hurdman JA, Condliffe RA, Elliot CA, Smith IA, Austin M, Armstrong IJ, Hamilton N, Charalampopoulos A, Sabroe I , Swift AJ et al (2017) Incremental Shuttle Walking Test Distance and Autonomic Dysfunction Predict Survival in Pulmonary Arterial Hypertension. The Journal of Heart and Lung Transplantation. View this article in WRRO
• Parry R, Armstrong I, Kiely D & Vora V (2017) P-131 Meeting the needs of patients with pulmonary arterial hypertension: an important role for a hospital palliative care team. BMJ Supportive & Palliative Care, 7(Suppl 1), A48.3-A49.
• Ramjug S, Hussain N, Hurdman J, Billings C, Charampopoulos A, Elliot CA, Kiely DG, Sabroe I, Rajaram S, Swift AJ & Condliffe R (2017) Idiopathic and Systemic Sclerosis associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Haemodynamic and Magnetic Resonance Imaging Characteristics and Outcomes.. Chest.
• Arno G, Carss KJ, Hull S, Zihni C, Robson AG, Fiorentino A, Hardcastle AJ, Holder GE, Cheetham ME, Plagnol V , Moore AT et al (2017) Biallelic Mutation of ARHGEF18 , Involved in the Determination of Epithelial Apicobasal Polarity, Causes Adult-Onset Retinal Degeneration. The American Journal of Human Genetics, 100(2), 334-342.
• Rhodes CJ, Ghataorhe P, Wharton J, Rue-Albrecht KC, Hadinnapola C, Watson G, Bleda M, Haimel M, Coghlan G, Corris PA , Howard LS et al (2017) Plasma Metabolomics Implicate Modified Transfer RNAs and Altered Bioenergetics in the Outcome of Pulmonary Arterial Hypertension.. Circulation, 135, 460-475. View this article in WRRO
• Carss KJ, Arno G, Erwood M, Stephens J, Sanchis-Juan A, Hull S, Megy K, Grozeva D, Dewhurst E, Malka S , Plagnol V et al (2017) Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease. The American Journal of Human Genetics, 100(1), 75-90.
• Sithamparanathan S, Nair A, Thirugnanasothy L, Coghlan JG, Condliffe R, Dimopoulos K, Elliot CA, Fisher AJ, Gaine S, Gibbs JSR , Gatzoulis MA et al (2016) Survival in portopulmonary hypertension: Outcomes of the united kingdom national pulmonary arterial hypertension registry. The Journal of Heart and Lung Transplantation.
• Hickey PM, Thompson AA, Charalampopoulos A, Elliot CA, Hamilton N, Kiely DG, Lawrie A, Sabroe I & Condliffe R (2016) Bosutinib therapy resulting in severe deterioration of pre-existing pulmonary arterial hypertension. European Respiratory Journal, 48(5), 1514-1514.
• Ramjug S, Hussain N, Hurdman J, Elliot CA, Sabroe I, Armstrong IJ, Billings C, Hamilton N, Kiely DG & Condliffe R (2016) Long-term outcomes of domiciliary intravenous iloprost in idiopathic and connective tissue disease-associated pulmonary arterial hypertension.. Respirology.
• Lungu A, Swift AJ, Capener D, Kiely D, Hose R & Wild JM (2016) Diagnosis of Pulmonary Hypertension from Magnetic Resonance Imaging–Based Computational Models and Decision Tree Analysis. Pulmonary Circulation, 6(2), 181-190. View this article in WRRO
• Cannon JE, Su L, Kiely DG, Page K, Toshner M, Swietlik E, Treacy C, Ponnaberanam A, Condliffe R, Sheares K , Taboada D et al (2016) Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort. Circulation, 133(18), 1761-1771.
• Goodwin AT, Wall J, Rajaram S, Amsha K & Kiely DG (2016) Breathlessness in an ex-miner: an unusual consideration. Thorax, 71(5), 481-482.
• Hussain N, Charalampopoulos A, Ramjug S, Condliffe R, Elliot CA, O'Toole L, Swift A & Kiely DG (2016) Pulmonary Hypertension in Patients with Heart Failure and Preserved Ejection Fraction: Differential Diagnosis and Management. Pulmonary Circulation, 6(1), 3-14.
• Galiè N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Noordegraaf AV, Beghetti M , Ghofrani A et al (2016) Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar. Revista Española de Cardiología, 69(2), 177.e1-177.e62.
• Ramjug S, Hussain N, Hurdman J, Billings C, Charalampopoulos A, Elliot CA, Sabroe I, Kiely DG & Condliffe R (2016) Pulmonary arterial hypertension associated with congenital heart disease: Comparison of clinical and anatomic–pathophysiologic classification. The Journal of Heart and Lung Transplantation, 35(5), 610-618. View this article in WRRO
• Galiè N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M , Ghofrani A et al (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal, 37(1), 67-119.
• Swift AJ, Saunders LC, Sproson T, Hussain N, Collier GJ, Marshall H, Kiely DG & Wild JM (2015) Multiparametric Magnetic Resonance Imaging in Pulmonary Hypertension. Current Cardiovascular Imaging Reports, 8(12).
• Rothman AMK, Arnold ND, Chang W, Watson O, Swift AJ, Condliffe R, Elliot CA, Kiely DG, Suvarna SK, Gunn J & Lawrie A (2015) Pulmonary Artery Denervation Reduces Pulmonary Artery Pressure and Induces Histological Changes in an Acute Porcine Model of Pulmonary Hypertension. Circulation: Cardiovascular Interventions, 8(11), e002569-e002569. View this article in WRRO
• Quadery R, Elliot CA, Hurdman J, Kiely DG, Maclean RM, Sabroe I, van Veen JJ & Condliffe R (2015) Management of acute pulmonary embolism. British Journal of Hospital Medicine, 76(10), C150-C155.
• Hemnes AR, Kiely DG, Cockrill BA, Safdar Z, Wilson VJ, Hazmi MA, Preston IR, MacLean MR & Lahm T (2015) Statement on Pregnancy in Pulmonary Hypertension from the Pulmonary Vascular Research Institute. Pulmonary Circulation, 5(3), 435-465.
• Swift AJ, Rajaram S, Capener D, Elliot C, Condliffe R, Wild JM & Kiely DG (2015) Longitudinal and Transverse Right Ventricular Function in Pulmonary Hypertension: Cardiovascular Magnetic Resonance Imaging Study from the ASPIRE Registry. Pulmonary Circulation, 5(3), 557-564.
• Stewart NJ, Leung G, Norquay G, Marshall H, Parra-Robles J, Murphy PS, Schulte RF, Elliot C, Condliffe R, Griffiths PD , Kiely DG et al (2015) Experimental validation of the hyperpolarized 129 Xe chemical shift saturation recovery technique in healthy volunteers and subjects with interstitial lung disease. Magnetic Resonance in Medicine, 74(1), 196-207. View this article in WRRO
• Swift AJ, Capener D, Hammerton C, Thomas SM, Elliot C, Condliffe R, Wild JM & Kiely DG (2015) Right Ventricular Sex Differences in Patients with Idiopathic Pulmonary Arterial Hypertension Characterised by Magnetic Resonance Imaging: Pair-Matched Case Controlled Study. PLOS ONE, 10(5), e0127415-e0127415. View this article in WRRO
• Rajaram S, Swift AJ, Condliffe R, Johns C, Elliot CA, Hill C, Davies C, Hurdman J, Sabroe I, Wild JM & Kiely DG (2015) CT features of pulmonary arterial hypertension and its major subtypes: a systematic CT evaluation of 292 patients from the ASPIRE Registry. Thorax, 70(4), 382-387. View this article in WRRO
• Levin D, Seo JB, Kiely DG, Hatabu H, Gefter W, van Beek EJR & Schiebler ML (2015) Triage for suspected acute Pulmonary Embolism: Think before opening Pandora's Box. European Journal of Radiology, 84(6), 1202-1211.
• Swift AJ, Rajaram S, Capener D, Elliot C, Condliffe R, Wild JM & Kiely DG (2014) LGE Patterns in Pulmonary Hypertension Do Not Impact Overall Mortality. JACC: Cardiovascular Imaging, 7(12), 1209-1217.
• Lungu A, Wild JM, Capener D, Kiely DG, Swift AJ & Hose DR (2014) MRI model-based non-invasive differential diagnosis in pulmonary hypertension. Journal of Biomechanics, 47(12), 2941-2947. View this article in WRRO
• Marshall H, Kiely DG, Parra-Robles J, Capener D, Deppe MH, van Beek EJR, Swift AJ, Rajaram S, Hurdman J, Condliffe R , Elliot CA et al (2014) Magnetic Resonance Imaging of Ventilation and Perfusion Changes in Response to Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine, 190(5), e18-e19. View this article in WRRO
• Condliffe R, Elliot CA, Hurdman J, Sabroe I, Billings C, Kiely DG & Hamilton N (2014) Ambrisentan therapy in pulmonary hypertension: clinical use and tolerability in a referral centre.. Ther Adv Respir Dis, 8(3), 71-77.
• Yorke J, Corris P, Gaine S, Gibbs SS, Kiely DG, Harries C, Pollock V & Armstrong I (2014) emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension.. European Respiratory Journal, 43, 1106-1113. View this article in WRRO
• Swift AJ, Telfer A, Rajaram S, Condliffe R, Marshall H, Capener D, Hurdman J, Elliot C, Kiely DG & Wild JM (2014) Dynamic contrast-enhanced magnetic resonance imaging in patients with pulmonary arterial hypertension.. Pulm Circ, 4(1), 61-70. View this article in WRRO
• Swift AJ, Wild JM, Nagle SK, Roldán-Alzate A, François CJ, Fain S, Johnson K, Capener D, van Beek EJR, Kiely DG , Wang K et al (2014) Quantitative magnetic resonance imaging of pulmonary hypertension: a practical approach to the current state of the art.. J Thorac Imaging, 29(2), 68-79.
• Condliffe R, Elliot CA, Hughes RJ, Hurdman J, Maclean RM, Sabroe I, van Veen JJ & Kiely DG (2014) Management dilemmas in acute pulmonary embolism.. Thorax, 69(2), 174-180. View this article in WRRO
• Swift AJ, Rajaram S, Campbell MJ, Hurdman J, Thomas S, Capener D, Elliot C, Condliffe R, Wild JM & Kiely DG (2014) Prognostic value of cardiovascular magnetic resonance imaging measurements corrected for age and sex in idiopathic pulmonary arterial hypertension.. Circ Cardiovasc Imaging, 7(1), 100-106.
• Swift A, Rajaram S, Capener D, Hill C, Davies C, Hurdman J, Condliffe R, Elliot C, Wild J & Kiely D (2013) Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease. EUROPEAN RESPIRATORY JOURNAL, 42.
• Ling Y, Johnson M, Kiely D, Condliffe R, Elliot C, Gibbs JSR, Howard L, Pepke-Zaba J, Sheares K, Corris P , Fisher A et al (2013) Prognostic predictors in younger and older incident idiopathic pulmonary arterial hypertension. EUROPEAN RESPIRATORY JOURNAL, 42.
• Ramjug S, Hurdman J, Hussain N, Sabroe I, Elliot C, Kiely D & Condliffe R (2013) Pulmonary hypertension associated with congenital heart disease (PH-CHD): Results from the ASPIRE registry. EUROPEAN RESPIRATORY JOURNAL, 42.
• Rajaram S, Swift AJ, Davies C, Hill C, Jenkins D, Goddard M, Condliffe R, Elliot CA, Wild JM & Kiely DG (2013) Primary pulmonary artery sarcoma and coexisting chronic thromboembolic pulmonary hypertension.. Am J Respir Crit Care Med, 188(5), e7-e8.
• Tapson VF, Jing ZC, Xu KF, Pan L, Feldman J, Kiely DG, Kotlyar E, McSwain CS, Laliberte K, Arneson C & Rubin LJ (2013) Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (The FREEDOM-C2 Study): A randomized controlled trial. Chest, 144(3), 952-958.
• Kiely DG, Condliffe R, Wilson V, Gandhi S & Elliot CA (2013) Pregnancy and pulmonary hypertension: a practical approach to management.. Obstetric Medicine(6), 144-154.
• Swift AJ, Rajaram S, Hurdman J, Hill C, Davies C, Sproson TW, Morton AC, Capener D, Elliot C, Condliffe R , Wild JM et al (2013) Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry.. JACC Cardiovasc Imaging, 6(10), 1036-1047.
• Hurdman J, Condliffe R, Elliot CA, Swift A, Rajaram S, Davies C, Hill C, Hamilton N, Armstrong IJ, Billings C , Pollard L et al (2013) Pulmonary hypertension in COPD: results from the ASPIRE registry.. Eur Respir J, 41(6), 1292-1301.
• Sammut D, Elliot CA, Kiely DG, Armstrong IJ, Martin L, Wilkinson J, Sephton P, Jones J, Hamilton N, Hurdman J , McLellan E et al (2013) Central venous catheter-related blood stream infections in patients receiving intravenous iloprost for pulmonary hypertension.. Eur J Clin Microbiol Infect Dis, 32(7), 883-889.
• Rhodes CJ, Wharton J, Boon RA, Roexe T, Tsang H, Wojciak-Stothard B, Chakrabarti A, Howard LS, Gibbs JSR, Lawrie A , Condliffe R et al (2013) Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension.. Am J Respir Crit Care Med, 187(3), 294-302.
• Snowden JA, Akil M & Kiely DG (2013) Improving safety in autologous HSCT for systemic sclerosis.. Lancet, 381(9872), 1081-1083.
• Swift AJ, Rajaram S, Capener D, Hurdman J, Elliot C, Condliffe R, Wild J & Kiely DG (2013) Longitudinal And Transverse Right Ventricular Function In Pulmonary Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 187.
• Rajaram S, Swift AJ, Condliffe R, Elliot C, Hurdman J, Christine D, Hill C, Wild J & Kiely DG (2013) CT Features Of Pulmonary Arterial Hypertension And Its Major Subtypes: A Study Of 292 Patients. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 187.
• Kiely DG & Howard LS (2013) Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertension.. Pulmonary Circulation, 1(3), 100-107.
• Howard LSGE, Watson GMJ, Wharton J, Rhodes CJ, Chan K, Khengar R, Robbins PA, Kiely DG, Condliffe R, Elliott CA , Pepke-Zaba J et al (2013) Supplementation of Iron in Pulmonary Hypertension: Rationale and Design of a Phase II Clinical Trial in Idiopathic Pulmonary Arterial Hypertension. Pulmonary Circulation, 3(1), 100-107.
• Kiely DG, Elliot CA, Sabroe I & Condliffe R (2013) Pulmonary hypertension: diagnosis and management.. BMJ, 346, f2028.
• Kawar B, Ellam T, Jackson C & Kiely DG (2013) Pulmonary hypertension in renal disease: epidemiology, potential mechanisms and implications.. Am J Nephrol, 37(3), 281-290.
• Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JSR, Howard LS, Pepke-Zaba J, Sheares KKK, Corris PA , Fisher AJ et al (2012) Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland.. Am J Respir Crit Care Med, 186(8), 790-796.
• Hameed AG, Arnold ND, Chamberlain J, Pickworth JA, Paiva C, Dawson S, Cross S, Long L, Zhao L, Morrell NW , Crossman DC et al (2012) Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension.. J Exp Med, 209(11), 1919-1935. View this article in WRRO
• Sitbon O, Baloira Villar A, Bauer F, Ekmehag B, Gin-Sing W, Jansson K, Kiely DG, Leuchte H, Manes A, Rosenkranz S & Escribano P (2012) Treat-to-target approach in pulmonary arterial hypertension: a consensus-based proposal.. Eur Respir Rev, 21(125), 259-262.
• Swift AJ, Rajaram S, Condliffe R, Capener D, Hurdman J, Elliot CA, Wild JM & Kiely DG (2012) Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry.. J Cardiovasc Magn Reson, 14, 40. View this article in WRRO
• Rajaram S, Swift AJ, Capener D, Elliot CA, Condliffe R, Davies C, Hill C, Hurdman J, Kidling R, Akil M , Wild JM et al (2012) Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease.. J Rheumatol, 39(6), 1265-1274.
• Hurdman J, Condliffe R, Elliot CA, Davies C, Hill C, Wild JM, Capener D, Sephton P, Hamilton N, Armstrong IJ , Billings C et al (2012) ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre.. Eur Respir J, 39(4), 945-955.
• Rajaram S, Swift AJ, Capener D, Telfer A, Davies C, Hill C, Condliffe R, Elliot C, Hurdman J, Kiely DG & Wild JM (2012) Lung morphology assessment with balanced steady-state free precession MR imaging compared with CT.. Radiology, 263(2), 569-577.
• Condliffe R, Pickworth JA, Hopkinson K, Walker SJ, Hameed AG, Suntharaligam J, Soon E, Treacy C, Pepke-Zaba J, Francis SE , Crossman DC et al (2012) Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension.. Pulm Circ, 2(1), 21-27. View this article in WRRO
• Swift AJ, Rajaram S, Marshall H, Condliffe R, Capener D, Hill C, Davies C, Hurdman J, Elliot CA, Wild JM & Kiely DG (2012) Black blood MRI has diagnostic and prognostic value in the assessment of patients with pulmonary hypertension.. Eur Radiol, 22(3), 695-702.
• Rajaram S, Swift AJ, Capener D, Telfer A, Davies C, Hill C, Condliffe R, Elliot C, Hurdman J, Kiely DG & Wild JM (2012) Diagnostic accuracy of contrast-enhanced MR angiography and unenhanced proton MR imaging compared with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension.. Eur Radiol, 22(2), 310-317.
• Kiely DG, Condliffe R, Webster V, Mills GH, Wrench I, Gandhi SV, Selby K, Armstrong IJ, Martin L, Howarth ES , Buʼlock FA et al (2011) Improved Survival in Pregnancy and Pulmonary Hypertension Using a Multiprofessional Approach. Obstetric Anesthesia Digest, 31(2), 122-122.
• Condliffe R, Kiely DG, Coghlan JG, Gibbs JSR, Wort SJ, Corris PA, Peacock AJ, Pepke-Zaba J & Unite APHS (2011) Survival in Pulmonary Hypertension Registries The Importance of Incident Cases. CHEST, 139(6), 1547-1548.
• Condliffe R, Radon M, Hurdman J, Davies C, Hill C, Akil M, Guarasci F, Rajaram S, Swift AJ, Wragg Z , van Beek E et al (2011) CT pulmonary angiography combined with echocardiography in suspected systemic sclerosis-associated pulmonary arterial hypertension.. Rheumatology (Oxford), 50(8), 1480-1486.
• Philips A, Hurdman J, Batuwitage B, Kiely D & Mills G (2011) Critical care outcome of pulmonary artery hypertension. Critical Care, 15(Suppl 1), P494-P494.
• Ling Y, Johnson M, Kiely DG, Condliffe R, Elliot CA, Gibbs S, Howard L, Pepke-Zaba J, Sheares K, Corris P , Lordan JL et al (2011) Survival Of Incident Cases Of Idiopathic, Heritable And Anorexigen-Associated Pulmonary Arterial Hypertension. Results From Pulmonary Hypertension Registry Of The United Kingdom And Ireland (Proud Registry). D34. PULMONARY HYPERTENSION: ENDPOINTS AND OUTCOMES.
• Condliffe R, Radon M, Hurdman J, Davies C, Hill C, Akil M, Guarasci F, Rajaram S, Swift AJ, Van Beek E , Elliot CA et al (2011) CT Pulmonary Angiography Combined With Echocardiography In Suspected Systemic Sclerosis-Associated Pulmonary Arterial Hypertension. A60. PULMONARY HYPERTENSION: DIAGNOSIS.
• Swift AJ, Rajaram S, Marshall H, Condliffe R, Capener D, Hill C, Davies C, Hurdman J, Elliot CA, Wild JM & Kiely DG (2011) Black blood MRI has diagnostic and prognostic value in the assessment of patients with pulmonary hypertension. European Radiology, 1-8.
• Lawrie A, Hameed AG, Chamberlain J, Arnold N, Kennerley A, Hopkinson K, Pickworth J, Kiely DG, Crossman DC & Francis SE (2011) Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner.. Am J Pathol, 179(4), 1693-1705. View this article in WRRO
• Ley S, Grünig E, Kiely DG, Van Beek E & Wild J (2010) Computed tomography and magnetic resonance imaging of pulmonary hypertension: Pulmonary vessels and right ventricle. Journal of Magnetic Resonance Imaging, 32(6), 1313-1324.
• Kiely DG, Condliffe R, Webster V, Mills GH, Wrench I, Gandhi SV, Selby K, Armstrong IJ, Martin L, Howarth ES , Bu'lock FA et al (2010) Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach.. BJOG, 117(5), 565-574.
• Fabreguet I, Kuet K, Akil M, Kilding R & Kiely D (2010) PULMONARY FUNCTIONAL IMPAIRMENT WITH ISOLATED LOW TRANSFER FACTOR IN SYSTEMIC SCLEROSIS. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 28(2), S150-S151.
• Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JSR, Pepke-Zaba J & Coghlan JG (2009) Survival in Systemic Sclerosis-related Pulmonary Arterial Hypertension in the Modern Treatment Era. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 180(12), 1280-1281.
• Hagger D, Condliffe R, Woodhouse N, Elliot CA, Armstrong IJ, Davies C, Hill C, Akil M, Wild JM & Kiely DG (2009) Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension.. Rheumatology (Oxford), 48(9), 1137-1142.
• Condliffe R, Kiely DG, Gibbs JSR, Corris PA, Peacock AJ, Jenkins DP, Goldsmith K, Coghlan JG & Pepke-Zaba J (2009) Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension. EUROPEAN RESPIRATORY JOURNAL, 33(2), 332-337.
• Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JSR, Vrapi F, Das C, Elliot CA, Johnson M, DeSoyza J , Torpy C et al (2009) Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.. Am J Respir Crit Care Med, 179(2), 151-157.
• van Beek EJR, Elliot CA & Kiely DG (2009) Diagnosis and initial treatment of patients with suspected pulmonary thromboembolism. Continuing Education in Anaesthesia, Critical Care and Pain, 9(4), 119-124.
• Beghetti M, Hoeper MM, Kiely DG, Carlsen J, Schwierin B, Segal ES & Humbert M (2008) Safety experience with bosentan in 146 children 2-11 years old with pulmonary arterial hypertension: Results from the European postmarketing surveillance program. PEDIATRIC RESEARCH, 64(2), 200-204.
• Condliffe R, Kiely DG, Gibbs JSR, Corris PA, Peacock AJ, Jenkins DP, Hodgkins D, Goldsmith K, Hughes RJ, Sheares K , Tsui SSL et al (2008) Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 177(10), 1122-1127.
• Gibbs JSR, Coghlan G, Corris PA, Gaine S, Gatzoulis MA, Haworth SG, Kiely DG, Peacock A, Pepke-Zaba J, Black C , Elliot C et al (2008) Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland. Heart, 94(SUPPL. 1).
• Harris H, Barraclough R, Davies C, Armstrong I, Kiely DG & van Beek E (2008) Cavitating lung lesions in chronic thromboembolic pulmonary hypertension.. J Radiol Case Rep, 2(3), 11-21.
• Condliffe R, Kiely DG, Peacock A, Corris PA, Gibbs JSR, Pepke-Zaba J & Coghlan JG (2007) Initial results of the united kingdom audit of pulmonary arterial hypertension associated with connective tissue disease (CTD-PAH). EUROPEAN HEART JOURNAL, 28, 139-140.
• Humbert M, Segal ES, Kiely DG, Carlsen J, Schwierin B & Hoeper MM (2007) Results of European post-marketing surveillance of bosentan in pulmonary hypertension. EUROPEAN RESPIRATORY JOURNAL, 30(2), 338-344.
• Smith AM, Elliot CM, Kiely DG & Channer KS (2006) The role of vasopressin in cardiorespiratory arrest and pulmonary hypertension.. QJM, 99(3), 127-133.
• Carisen J, Kiely DG, Hoeper MM, Segal E & Humbert M (2006) Combination of bosentan with prostanoids or sildenafil in pulmonary arterial hypertension was well tolerated: Results from the TRAX database. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 25(2), S75-S76.
• Elliot CA & Kiely DG (2006) Pulmonary hypertension. Continuing Education in Anaesthesia, Critical Care and Pain, 6(1), 17-22.
• Elliot CA, Stewart P, Webster VJ, Mills GH, Hutchinson SP, Howarth ES, Bu'lock FA, Lawson RA, Armstrong IJ & Kiely DG (2005) The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension.. Eur Respir J, 26(1), 168-173.
• Demoncheaux EAG, Higenbottam TW, Kiely DG, Wong J-M, Wharton S, Varcoe R, Siddons T, Spivey AC, Hall K & Gize AP (2005) Decreased whole body endogenous nitric oxide production in patients with primary pulmonary hypertension.. J Vasc Res, 42(2), 133-136.
• Kiely DG, Kennedy NS, Pirzada O, Batchelor SA, Struthers AD & Lipworth BJ (2005) Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism. Respiratory Medicine, 99(10), 1286-1291.
• Elliot C & Kiely DG (2004) Pulmonary hypertension: diagnosis and treatment.. Clin Med (Lond), 4(3), 211-215.
• Eneser M, Emery CJ, Amsha K, Kiely DG, Barer GR, Wallace W & Higenbottam TW (2002) Histological evidence of pulmonary hypertension in normotensive but symptomatic patients. JOURNAL OF PATHOLOGY, 198, 47A-47A.
• Olschewski H, Simonneau G, Galie N, Higenbottam T, Naeije R, Rubin LJ, Nikkho S, Speich R, Hoeper MM, Behr J , Winkler J et al (2002) Inhaled iloprost for severe pulmonary hypertension. NEW ENGL J MED, 347(5), 322-329.
• Amsha K, Armstrong I, Taylor EA, Lawson RA & Kiely DG (2001) Clinical features of bacteraemia complicating IV prostaglandin therapy in patients with pulmonary hypertension. THORAX, 56, 78-78.
• Kiely DG, Ansari S, Davey WA, Mahadevan V, Taylor GJ & Seaton D (2001) Bedside tracer gas technique accurately predicts outcome in aspiration of spontaneous pneumothorax. THORAX, 56(8), 617-621.
• Kiely DG, Davey WA, Mahadevan V & Seaton D (2001) Latrogenic pneumothorax: Marker gas technique for predicting outcome of manual aspiration. RESPIRATION, 68(2), 165-168.
• Kiely DG, Braithwaite KL, Rabbits PH, Khoo J, Gilligan DG, Goddard M & Laroche CM (2000) Detection of loss of heterozygosity in plasma DNA of patients with lung cancer. Thorax, 55(SUPPL. 3).
• Kiely DG, Mahadevan V, Davey WA, Taylor G & Seaton D (2000) Bedside tracer gas technique accurately predicts outcome of spontaneous pneumothorax. THORAX, 55, A73-A73.
• Kiely DG, Mahadevan V, Davey WA, Taylor G & Seaton D (2000) Volume aspirated is an indicator of the success of manual aspiration in the treatment of spontaneous pneumothorax. THORAX, 55, A74-A74.
• Kiely DG, Cargill RI & Lipworth BJ (2000) Effects of acute oxygen therapy on left ventricular diastolic filling in hypoxaemic cor pulmonale. ACP-APPLIED CARDIOPULMONARY PATHOPHYSIOLOGY, 9(1), 27-31.
• Lee AFC, Kiely DG, Coutie WJ & Struthers AD (1999) The effect of nitric oxide inhibition on the renin response to frusemide, in man. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 48(3), 355-360.
• Kiely DG, Davey WA, Ansari S, Mahadevan V & Seaton D (1999) Predicting outcome of manual aspiration in the treatment of pneumothorax using a marker gas technique. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 159(3), A387-A387.
• Kiely DG, Pearce L, O'Reilly D & Laroche CM (1998) Improved outcome from Chronic Obstructive Pulmonary Disease (COPD) exacerbations in a district general hospital following introduction of an oxygen prescription and guidance form. Thorax, 53(SUPPL. 4).
• Kiely DG, Davey WA, Mahadevan V & Seaton D (1998) Iatrogenic pneumothorax: Marker gas technique for predicting outcome of manual aspiration. Thorax, 53(SUPPL. 4).
• Kiely DG, Lee AFC, Struthers AD & Lipworth BJ (1998) Nitric oxide: an important role in the maintenance of systemic and pulmonary vascular tone in man. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 46(3), 263-266.
• Lipworth BJ & Kiely D (1997) Use of pulsed-wave Doppler echocardiography to measure changes in MPAP - Is further validation required?. CHEST, 111(5), 1470-1470.
• Kiely DG, Cargill RI & Lipworth BJ (1997) Effects of frusemide and hypoxia on the pulmonary vascular bed in man. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 43(3), 309-313.
• Kiely DG, Cargill RI, Struthers AD & Lipworth BJ (1997) Cardiopulmonary effects of endothelin-1 in man. CARDIOVASCULAR RESEARCH, 33(2), 378-386.
• Morrell NW (1997) Use of Pulsed-Wave Doppler Echocardiography to Measure Changes in MPAP. Chest, 111(5), 1469-1470.
• Kiely DG, Cargill RI, Wheeldon NM, Coutie WJ & Lipworth BJ (1997) Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale. CARDIOVASCULAR RESEARCH, 33(1), 201-208.
• Kiely DG, Kennedy NJ, Coutie WJ, Struthers AD, Batchelor SA & Lipworth BJ (1996) A role for natriuretic peptides in the diagnosis of pulmonary thromboembolism. Thorax, 51(SUPPL. 3).
• Kiely DG, Cargill RI & Lipworth BJ (1996) Angiotensin II receptor blockade and effects on pulmonary hemodynamics and hypoxic pulmonary vasoconstriction in humans. CHEST, 110(3), 698-703.
• Kiely DG, Cargill RI & Lipworth BJ (1996) Effects of hypercapnia on hemodynamic, inotropic, lusitropic, and electrophysiologic indices in humans. CHEST, 109(5), 1215-1221.
• Kiely DG, Cargill RI & Lipworth BJ (1996) Acute Hypoxic Pulmonary Vasoconstriction in Man is Attenuated by Type 1 Angiotensin II Receptor Blockade. Clinical Science, 90(s34), 5P-5P.
• Kiely DG, Cargill RI & Lipworth BJ (1996) Hypoxaemia and Release of Endothelin-1 in Humans. Clinical Science, 90(s34), 4P-5P.
• Kiely DG, Cargill RI, Struthers AD & Lipworth BJ (1996) Systemic and Pulmonary Haemodynamic Effects of Endothelin-1 in Humans. Clinical Science, 90(s34), 4P-4P.
• CARGILL RI, KIELY DG, CLARK RA & LIPWORTH BJ (1995) HYPOXEMIA AND RELEASE OF ENDOTHELIN-1. THORAX, 50(12), 1308-1310.
• Kiely DG, Cargill RI & Lipworth BJ (1995) Acute hypoxic pulmonary vasoconstriction in man is attenuated by type I angiotensin II receptor blockade. CARDIOVASCULAR RESEARCH, 30(6), 875-880.
• KIELY DG, CARGILL RI, GROVE A, STRUTHERS AD & LIPWORTH BJ (1995) ABNORMAL MYOCARDIAL REPOLARIZATION IN RESPONSE TO HYPOXEMIA AND FENOTEROL. THORAX, 50(10), 1062-1066.
• KIELY DG, CARGILL RI & LIPWORTH BJ (1995) CARDIOPULMONARY INTERACTIONS OF SALBUTAMOL AND HYPOXEMIA IN HEALTHY-YOUNG VOLUNTEERS. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 40(4), 313-318.
• CARGILL RI, KIELY DG & LIPWORTH BJ (1995) LEFT-VENTRICULAR SYSTOLIC PERFORMANCE DURING ACUTE HYPOXEMIA. CHEST, 108(4), 899-902.
• CARGILL RI, KIELY DG & LIPWORTH BJ (1995) ADVERSE-EFFECTS OF HYPOXEMIA ON DIASTOLIC FILLING IN HUMANS. CLINICAL SCIENCE, 89(2), 165-169.
• Kiely DG, Cargill RI & Lipworth BJ (1995) Pre-Treatment with Frusemide Augments Hypoxic Pulmonary Vasoconstriction. Clinical Science, 89(s33), 28P-29P.
• CARGILL RI, KIELY DG & LIPWORTH BJ (1994) HYPOXEMIA AND THE RENIN-ANGIOTENSIN SYSTEM - NEW ANSWERS FOR OLD QUESTIONS. PULMONARY PHARMACOLOGY, 7(5), 279-284.
• Kendrew R, Ajraoui S, Beaudet A, Kelly K, Kiely DG, Rothman A, Varian F, Davis S & Pillai N () Relevance of patient-centered actigraphy measures in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a qualitative interview study. BMC Pulmonary Medicine, 24(1).
• Abdulaal L, Maiter A, Dwivedi K, Sharkey MJ, Alabed S, Alkhanfar D, Rothman A, Rajaram S, Condliffe R, Kiely DG & Swift AJ () Lung parenchymal and cardiac appearances on CTPA impact survival in chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry. ERJ Open Research, 00732-2024.
• Salehi M, Alabed S, Sharkey M, Maiter A, Dwivedi K, Yardibi T, Selej M, Hameed A, Charalampopoulos A, Kiely DG & Swift AJ () Artificial intelligence-based echocardiography assessment to detect pulmonary hypertension. ERJ Open Research, 00592-2024.
• Delcroix M, Pepke-Zaba J, D’Armini AM, Fadel E, Guth S, Hoole SP, Jenkins DP, Kiely DG, Kim NH, Madani MM , Matsubara H et al () Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy. Circulation.
• Rajagopal S, Bogaard HJ, Elbaz MSM, Freed BH, Remy-Jardin M, van Beek EJR, Gopalan D & Kiely DG () Emerging multimodality imaging techniques for the pulmonary circulation. European Respiratory Journal, 2401128-2401128.
• Goh ZM, Johns CS, Julius T, Barnes S, Dwivedi K, Elliot C, Sharkey M, Alkanfar D, Charalampololous T, Hill C , Rajaram S et al () Unenhanced computed tomography as a diagnostic tool in suspected pulmonary hypertension: a retrospective cross-sectional pilot study. Wellcome Open Research, 6, 249-249.
• McLaughlin VV, Sitbon O, Chin KM, Galiè N, Hoeper MM, Kiely DG, MacDonald G, Martin N, Mathai SC, Peacock A , Tawakol A et al () Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbidities. European Journal of Heart Failure.
• Álvarez-Hernández MP, Allanore Y, Andrade I, Buch MH, Coghlan G, Del Galdo F, Denton CP, Khanna D, Kiely DG, Pauling JD , Ramjug S et al () Attitudes and barriers to pulmonary arterial hypertension screening in systemic sclerosis patients: A survey of UK-based rheumatologists. Journal of Scleroderma and Related Disorders.
• Durrington C, Hurdman JA, Elliot CA, Maclean R, Van Veen J, Sacccullo G, De-Foneska D, Swift AJ, Rajaram S, Hill C , Thomas S et al () Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE Registry. European Respiratory Journal, 2300846-2300846.
• Pepke-Zaba J, Howard L, Kiely DG, Sweeney S & Johnson M () Pulmonary Embolism (PE) to Chronic Thromboembolic Pulmonary Disease (CTEPD): Findings from a Survey of UK Physicians. Advances in Respiratory Medicine, 92(1), 45-57.
• Grafton-Clarke C, Matthews G, Gosling R, Swoboda P, Rothman A, Wild JM, Kiely DG, Condliffe R, Alabed S, Swift AJ & Garg P () The Left Atrial Area Derived Cardiovascular Magnetic Resonance Left Ventricular Filling Pressure Equation Shows Superiority over Integrated Echocardiography. Medicina, 59(11), 1952-1952.
• Khassafi F, Chelladurai P, Valasarajan C, Nayakanti SR, Martineau S, Sommer N, Yokokawa T, Boucherat O, Kamal A, Kiely DG , Swift AJ et al () Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertension. Nature Cardiovascular Research.
• Condliffe R, Newton R, Bauchmuller K, Bonnett T, Kerry R, Mannings A, Nair A, Selby K, Skinner PP, Wilson VJ & Kiely DG () Surgery and Anesthesia in Patients with Pulmonary Hypertension. Seminars in Respiratory and Critical Care Medicine.
• Karia N, Howard L, Johnson M, Kiely DG, Lordan J, McCabe C, Pepke-Zaba J, Ong R, Preiss M, Knight D , Muthurangu V et al () Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study. European Heart Journal.
• Alabed S, Garg P, Alandejani F, Dwivedi K, Maiter A, Karunasaagarar K, Rajaram S, Hill C, Thomas S, Gossling R , Sharkey M et al () Establishing minimally important differences for cardiac MRI endpoints in pulmonary arterial hypertension. European Respiratory Journal, 2202225-2202225.
• Carusi A, Winter PD, Armstrong I, Ciravegna F, Kiely DG, Lawrie A, Lu H, Sabroe I & Swift A () Medical artificial intelligence is as much social as it is technological. Nature Machine Intelligence.
• Kheyfets VO, Sweatt AJ, Gomberg-Maitland M, Ivy DD, Condliffe R, Kiely DG, Lawrie A, Maron BA, Zamanian RT & Stenmark KR () Computational platform for doctor-AI cooperation in PAH prognostication: a pilot study. ERJ Open Research, 00484-2022.
• Keen C, Smith I, Hashmi-Greenwood M, Sage K & Kiely DG () Pulmonary hypERtension and measurement of exerciSe caPacIty REmotely: evaluation of the 1-minute sit to stand test (PERSPIRE): a cohort study. ERJ Open Research, 00295-2022.
• Sharkey MJ, Taylor JC, Alabed S, Dwivedi K, Karunasaagarar K, Johns CS, Rajaram S, Garg P, Alkhanfar D, Metherall P , O'Regan DP et al () Fully automatic cardiac four chamber and great vessel segmentation on CT pulmonary angiography using deep learning. Frontiers in Cardiovascular Medicine, 9.
• Fishwick D & Kiely DG () Vascular compression and pulmonary hypertension: the occupational context. Occupational and Environmental Medicine.
• Dixon PH, Levine AP, Cebola I, Chan MMY, Amin AS, Aich A, Mozere M, Maude H, Mitchell AL, Zhang J , Adlard J et al () GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements. Nature Communications, 13(1).
• Shahin Y, Alabed S, Alkhanfar D, Tschirren J, Rothman AMK, Condliffe R, Wild JM, Kiely DG & Swift AJ () Quantitative CT Evaluation of Small Pulmonary Vessels Has Functional and Prognostic Value in Pulmonary Hypertension. Radiology.
• Alkhanfar D, Shahin Y, Alandejani F, Dwivedi K, Alabed S, Johns C, Lawrie A, Thompson AAR, Rothman AMK, Tschirren J , Uthoff JM et al () Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative CT. ERJ Open Research, 00503-2021.
• Shahin Y, Alabed S, Rehan Quadery S, Lewis RA, Johns C, Alkhanfar D, Sukhanenko M, Alandejani F, Garg P, Elliot CA , Hameed A et al () CMR Measures of Left Atrial Volume Index and Right Ventricular Function Have Prognostic Value in Chronic Thromboembolic Pulmonary Hypertension. Frontiers in Medicine, 9.
• Condliffe R, Bauchmuller K, Southern J, Kiely DG & Mills GH () Comment on “External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension”. ERJ Open Research, 00066-2022.
• Rhodes CJ, Wharton J, Swietlik EM, Harbaum L, Girerd B, Coghlan JG, Lordan J, Church C, Pepke-Zaba J, Toshner M , Wort SJ et al () Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine.
• Wardle M, Nair A, Saunders S, Armstrong I, Charalampopoulos A, Elliot C, Hameed A, Hamilton N, Harrington J, Keen C , Lewis R et al () Elective lower limb orthopaedic arthroplasty surgery in patients with pulmonary hypertension. Pulmonary Circulation.
• Snowden JA, Styczyński J, Snarski E & Greco R () Hematopoietic stem cell transplantation in autoimmune diseases: update from EBMT Autoimmune Diseases Working Party with special reference to Poland. Acta Haematologica Polonica, 52(4), 217-224.
• Church C, Gin-Sing W, Grady D, Johnson M, Kiely DG, Lordan J, Turner N, Wort SJ & Condliffe R () Establishing expert consensus for the optimal approach to holistic risk-management in pulmonary arterial hypertension: a Delphi process and narrative review. Expert Review of Respiratory Medicine, 1-11.
• Rothman AMK, Arnold ND, Abou-Hanna J, Forouzan O, Swift AJ, Dahaghin P, Konganige S, Middleton JT, Zafar H, Suvarna SK , Kiely DG et al () Feasibility and safety of a telemetric pulmonary artery pressure monitoring system in acute and chronic porcine models of pulmonary hypertension.
• Keen C, Harrop D, Hashmi-Greenwood MN, Kiely DG, Yorke J & Sage K () Outcome Measures Used in Studies of Rehabilitation in Pulmonary Hypertension: A Systematic Review. Annals of the American Thoracic Society.
• Billings CG, Lewis R, Armstrong IJ, Hurdman JA, Smith IA, Austin M, Elliot CA, Charalampopoulos A, Sabroe I, Lawrie A , Thompson AAR et al () Incremental Shuttle Walking Test Distance Is Reduced in Patients With Pulmonary Hypertension in World Health Organisation Functional Class I. Frontiers in Medicine, 5. View this article in WRRO
• McCullagh BN, Costello CM, Li L, O’Connell C, Codd M, Lawrie A, Morton A, Kiely DG, Condliffe R, Elliot C , McLoughlin P et al () Elevated Plasma CXCL12α Is Associated with a Poorer Prognosis in Pulmonary Arterial Hypertension. PLOS ONE, 10(4), e0123709-e0123709. View this article in WRRO
• Condliffe R, Elliot CA & Kiely DG () Management of Suspected Chronic Thromboembolic Pulmonary Hypertension, 405-420.
• Bauchmuller K, Condliffe R, Southern J, Billings C, Charalampopoulos A, Elliot CA, Hameed A, Kiely DG, Sabroe I, Thompson AAR , Raithatha A et al () Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry. ERJ Open Research, 00046-2021.
• Shahin Y, Rajaram S, Parkash V, Wild J, Kiely DG & Swift A () EXPRESS: Patterns of Thromboembolic Pulmonary Vascular Disease in COVID-19. Pulmonary Circulation, 204589402097919-204589402097919.
• Goh ZM, Johns CS, Julius T, Barnes S, Dwivedi K, Elliot C, Sharkey M, Alkanfar D, Charalampololous T, Hill C , Rajaram S et al () Unenhanced computed tomography as a diagnostic tool in suspected pulmonary hypertension: a retrospective cross-sectional pilot study. Wellcome Open Research, 6, 249-249.
• Thompson AAR, Wilkins MR, Wild JM, Kiely DG & Lawrie A () Editorial : pulmonary hypertension : mechanisms and management, history and future. Frontiers in Medicine, 7. View this article in WRRO
• Sharrack B, Saccardi R, Alexander T, Badoglio M, Burman J, Farge D, Greco R, Jessop H, Kazmi M, Kirgizov K , Labopin M et al () Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases : updated guidelines and recommendations from the EBMT autoimmune diseases working party (ADWP) and the joint accreditation committee of EBMT and ISCT (JACIE). Bone Marrow Transplantation. View this article in WRRO
• Saunders LC, Hughes PJC, Alabed S, Capener DJ, Marshall H, Vogel‐Claussen J, Beek EJR, Kiely DG, Swift AJ & Wild JM () Integrated Cardiopulmonary MRI Assessment of Pulmonary Hypertension. Journal of Magnetic Resonance Imaging.

Chapters

• Kiely DG & Condliffe R (2021) Systemic Sclerosis and the Lung, Hematopoietic Stem Cell Transplantation and Cellular Therapies for Autoimmune Diseases (pp. 463-478). CRC Press
• ten Klooster L, Wilson VJ, Newton R, Selby K, Gandhi SV & Kiely DG (2020) Pulmonary Hypertension and Pregnancy, Respiratory Disease in Pregnancy (pp. 99-112). Cambridge University Press
• Wilson V, Kiely D, Gandhi S, Selby K, Newton R & ten Klooster L (2020) Pulmonary Hypertension and pregnancy In lapinski & plante (Ed.), Respiratory Disease in Pregnancy Cambridge University Press
• Hickey PM, Condliffe R, Lawrie A & Kiely DG (2018) Pulmonary Hypertension, Foundations of Respiratory Medicine (pp. 315-330). Springer International Publishing
• Wilson V, Kiely D, Elliot CA, Gandhi S & Condliffe R (2016) Management of pulmonary hypertension in pregnancy In steer & gatzoulis (Ed.), Heart Disease and Pregnancy RCOG
• Condliffe RA, Elliot CA & Kiely DG (2009) Deep Vein Thrombosis and Pulmonary Embolism In Beek EJRV, Büller HR & Oudkerk M (Ed.), Deep Vein Thrombosis and Pulmonary Embolism (pp. 405-420). Wiley
• Kiely DG, Elliot CA, Webster VJ & Stewart P (2006) Heart Disease and Pregnancy In Steer PJ, Gatzoulis MA & Baker P (Ed.), Heart Disease and Pregnancy (pp. 211-229). Rcog
• Kiely DG, Elliot CA, Wilson VJ, Gandhi SV & Condliffe R () Management of pulmonary hypertension in pregnancy, Heart Disease and Pregnancy (pp. 144-159). Cambridge University Press

Conference proceedings papers

• Dwivedi K, Sharkey M, Delany L, Alabed S, Rajaram S, Hill C, Johns C, Rothman A, Thompson R, Condliffe R , Kiely D et al (2023) Improved quantification and prognostication of lung disease on CT in pulmonary hypertension by combining the strengths of deep learning and radiologists: a retrospective multicentre study with external validation. The Royal College of Radiologists Open, Vol. 1 (pp 100096-100096)
• Bunclark K, Fletcher A, Ruggiero A, Cannon J, Coghlan G, Lordan J, Howard L, Jenkins D, Johnson M, Kiely D , Ng C et al (2023) Left ventricular diastolic dysfunction attenuates outcomes in CTEPH. Pulmonary hypertension
• Dwivedi K, Sharkey M, Delany L, Alabed S, Rajaram S, Hill C, Johns C, Rothman A, Thompson R, Wild J , Condliffe R et al (2023) Artificial Intelligence and Computed Tomography to improve quantification and prognostication of lung disease in precapillary pulmonary hypertension. Pulmonary hypertension
• Bunclark K, Liley J, Ruggiero A, Cannon J, Coghan G, Lordan J, Howard L, Jenkins D, Johnson M, Kiely D , Ng C et al (2023) An open-source tool for risk prediction in operable CTEPH. Pulmonary hypertension
• Wort J, Behr J, Cottin V, Kiely D, Kreuter M, Sitbon O, Chekroun Martinot A, Proenca CC, Fernández Delgado M & Bacchini Jeanneret G (2023) A real-word evidence study of PH-LD, PH-ILD and PAH in France, Germany, and the UK. Pulmonary hypertension
• Alabed S, Garg P, Alandejani F, Dwivedi K, Maiter A, Gossling R, Sharkey M, Salehi M, van der Geest RJ, Swift AJ & Kiely DG (2023) P10 Defining cardiac MRI change thresholds based on how a patient feels, functions and survives post pulmonary arterial hypertension treatment. Scientific poster abstracts
• Patel J, Kiely DG, Roddis C, Charalampopoulos A, Thompson R, Pearson C, Dick J, Binmahfooz S, Lewis R, Taylor J , Ashraf C et al (2023) 196 The relationship of physical activity, heart rate variability, and night heart rate to established measures of clinical risk in patients with pulmonary arterial hypertension (pah). Stable IHD/Prevention/Hypertension/Lipids
• Varian F, Binmahfooz S, Condliffe R, Middleton JT, Rothman AMK, Patel J, Kiely DG, Hamilton N, Lewis R, Elliot C , Battersby C et al (2023) 158 Remote personalisation of pulmonary arterial hypertension therapy and application of a remote physiological risk score. Heart Failure
• Battersby C, Condliffe R, Kiely DG, Elliot C, Middleton JT, Patel J, Neelam-Naganathan D, Lewis R, Binmahfooz S, Swift AJ , Hameed A et al (2023) 155 Effect of covid-19 infection and preventive public health measures on haemodynamics, activity and quality of life in patients with pulmonary arterial hypertension. Heart Failure
• Ashraf C, Taylor J, Roddis C, Toshner M, Middleton JT, Hurdman J, Thompson R, Kiely DG, Swift AJ, Charalampopoulos A , Roman S et al (2023) 154 Stability of daily physical activity as a remote measure of clinical risk in pulmonary arterial hypertension (pah). Heart Failure
• Taylor J, Kiely DG, Hamilton N, Hurdman J, Dwivedi K, Pearson C, Charalampopoulos A, Zafar H, Reddy A, Lewis R , Patel J et al (2023) 153 Differences in physical activity, heart rate and heart variability during clinical worsening events in patients with pulmonary arterial hypertension (pah). Heart Failure
• Middleton J, Neelam-Naganathan D, Elliot C, Taylor J, Toshner M, Zafar H, Lewis R, Ashraf C, Binmahfooz S, Condliffe R , Durrington C et al (2023) 138 Physiological detection of clinical worsening and therapeutic response using implanted remote technologies in pah. Heart Failure
• Middleton J, Elliot C, Pearson C, Battersby C, Roman S, Armstrong I, Condliffe R, Watson L, Rothman AMK, Neelam-Naganathan D , Kiely DG et al (2023) 137 Design and validation of a physiological risk score for pulmonary arterial hypertension (pah). Heart Failure
• Durrington C, Hurdman J, Armstrong I, Charalampopoulos A, Condliffe R, Elliot C, De-Fonseka D, Hameed AG, Hamilton N, Hill C , Maclean R et al (2023) Systematic Follow-up of Patients Following Acute Pulmonary Embolism Identifies High Incidence of Chronic Thromboembolic Pulmonary Hypertension: ASPIRE CTEPH. D106. HOT OFF THE PRESSES! LATE BREAKERS IN PULMONARY VASCULAR DISEASE
• Dwivedi K, Sharkey MJ, Alabed S, Condliffe R, Swift AJ & Kiely D (2023) Quantitative Computed Tomography Lung Parenchymal Features Can Aid in Phenotyping of Group 1 and Group 3 Pulmonary Hypertension. B60. LIFE MOVES FAST! LATE BREAKERS IN PULMONARY HYPERTENSION
• Durrington C, Battersby C, Holt L, Fairman A, salisbury T, Turton H, Watson L, Hameed A, Charalampopoulos A, Elliot C , Rothman A et al (2023) Assessing the Repeatability of NT-proBNP Testing Using Laboratory and Point of Care Testing in PAH (REPEAT-PAH). B57. INTERMEDIATES, CORRELATES, AND SURROGATES, OH MY!: NOVEL END POINTS AND ASSESSMENTS IN PVD
• Alabed S, Garg P, Alandejani F, Dwivedi K, Maiter A, Karunasaagarar K, Rajaram S, Hill C, Thomas S, Gossling R , Sharkey M et al (2023) 33 Cardiac MRI thresholds for improvement in pulmonary arterial hypertension. Abstracts
• Haque A, Divwedi K, Lewis R, Charalampopoulos A, Elliot C, Hameed A, Hamilton N, Ramjug S, Rothman A, Swift A , Thompson R et al (2022) The effect of parenchymal lung disease on patient characteristics and outcome in SSc-PH: Insights from the ASPIRE registry. 13.01 - Pulmonary hypertension
• Sharkey M, Karunasaagarar K, Johns CS, Rajaram S, Dwivedi K, Garg P, Alkhanfar D, Alabed S, Metherall P, Taylor J , Van Der Geest RJ et al (2022) Fully automatic deep learning pulmonary hypertension diagnosis using CT pulmonary angiography. 13.01 - Pulmonary hypertension
• Alabed S, Dwivedi K, Durrington C, Alandejani F, Lewis R, Eelliot C, Charalampopoulos A, Thompson R, Hameed A, Rothman A , Armstrong I et al (2022) Correlation of emPHasis-10 with clinical tests: insights from the ASPIRE registry. 13.01 - Pulmonary hypertension
• Dwivedi K, Sharkey M, Lewis R, Mamalakis M, Alabed S, Rajaram S, Hill C, Kiely D, Wild J, Swift A & Condliffe R (2022) Prognostic importance of centrilobular ground glass changes in patients with Idiopathic Pulmonary Arterial Hypertension. 13.01 - Pulmonary hypertension
• Haque A, Charalampopoulos A, Dwivedi K, Elliot C, Hameed A, Hamilton N, Lewis R, Ramjug S, Rothman A, Thompson R , Swift A et al (2022) New diagnostic criteria and PVR thresholds in SSc-associated PH: Insights from the ASPIRE registry. 13.01 - Pulmonary hypertension
• Goh ZM, Balasubramanian N, Alabed S, Dwivedi K, Shahin Y, Mk Rothman A, Garg P, Lawrie A, Capener D, Thompson AR , Alandejani F et al (2022) CMR assessed maladaptive right ventricular remodelling predicts treatment failure in pulmonary arterial hypertension. 13.01 - Pulmonary hypertension
• Keen C, Hashmi-Greenwood M, Sage K & Kiely D (2022) Pulmonary Hypertension and measurement of exercise capacity remotely: the PERSPIRE study. 01.05 - Clinical respiratory physiology, exercise and functional imaging
• Kiely D, Grünig E, Balasubramanian V, Barberà J, Vizza CD, Elwing J, Sood N, Rao Y, Holdstock L, Seaman S , Broderick M et al (2022) Efficacy of oral treprostinil as an add-on therapy for PAH. 13.01 - Pulmonary hypertension
• Patel J, Middleton J, Battersby C, Zafar H, Binmahfooz S, Neelam-Naganathan D, Toshner M, Reddy A, Lewis R, Watson L , Swift A et al (2022) S91 Remote monitored physical activity is related to established measures of clinical risk in patients with pulmonary arterial hypertension. ‘The Sixth Sense’ – Prognostication in pulmonary vascular disease
• Alabed S, Dwivedi K, Durrington C, Alandajani F, Condliffe R, Elliot C, Charalampopoulos A, Hameed A, Thompson R, Rothman A , Armstrong I et al (2022) P37 Correlation of emPHasis-10 with clinical tests: insights from the ASPIRE registry. ‘Mission (Im)possible I’ – Pulmonary vascular disease
• Battersby CP, Middleton JT, Zafar H, Binmahfooz SK, Patel J, Neelam-Naganathan D, Toshner M, Reddy A, Lewis R, Watson L , Swift A et al (2022) P81 Effect of COVID-19 infection and preventive public health measures on haemodynamics, activity and quality of life in patients with pulmonary arterial hypertension. ‘Contagion’ – The impact of COVID-19
• Durrington C, Battersby C, Holt L, Fairman A, Salisbury T, Turton H, Watson L, Hameed AG, Charalampopoulos A, Elliot CA , Rothman AMK et al (2022) P38 Assessing the repeatability of NT-proBNP testing using laboratory and point of care testing in PAH (REPEAT-PAH). ‘Mission (Im)possible I’ – Pulmonary vascular disease
• Goh ZM, Balasubramanian N, Alabed S, Dwivedi K, Shahin Y, Rothman AMK, Garg P, Lawrie A, Capener D, Thompson AAR , Alandejani F et al (2022) S90 Right ventricular remodelling assessed using cardiac magnetic resonance predicts survival and treatment response in pulmonary arterial hypertension. Thorax, Vol. 77(Suppl 1) (pp a55-a56). Westminster, London, United Kingdom, 23 November 2022 - 23 November 2022. View this article in WRRO
• Alabed S, Garg P, Alandejani F, Dwivedi K, Maiter A, Karunasaagarar K, Rajaram S, Hill C, Thomas S, Sharkey M , Wild JM et al (2022) P39 Establishing minimally important differences for cardiac MRI endpoints in pulmonary arterial hypertension. Thorax, Vol. 77(Suppl 1) (pp A101-A102). Westminster, London, United Kingdom, 23 November 2022 - 23 November 2022. View this article in WRRO
• Abdulaal L, Dwivedi K, Sharkey MJ, Alabed S, Mamalakis M, Alkhanfar D, Condliffe R, Kiely DG & Swift AJ (2022) P41 CT lung parenchymal appearances in chronic thromboembolic pulmonary hypertension (CTEPH). ‘Mission (Im)possible I’ – Pulmonary vascular disease
• Pepke-Zaba J, Howard L, Kiely D, Donovan-Rodriguez T & Johnson M (2022) P42 Pulmonary embolism (PE) to chronic thromboembolic pulmonary disease (CTEPD): Findings from a survey of UK physicians. ‘Mission (Im)possible I’ – Pulmonary vascular disease
• Middleton JT, Binmafooz S, Zafar H, Patel J, Giri D, Battersby C, Toshner M, Reddy A, Lewis R, Durrington C , Swift A et al (2022) S92 Remote monitoring enabled evaluation of risk and physiological response to therapeutic escalation and clinical worsening in patients with pulmonary hypertension. ‘The Sixth Sense’ – Prognostication in pulmonary vascular disease
• Durrington C, Armstrong I, Charalampopoulos A, Condliffe R, Devey T, Elliot C, Hameed A, Hamilton N, Hill C, Hurdman J , Lewis RA et al (2022) S93 Systematic follow-up of patients following acute pulmonary embolism is associated with an increased incidence of chronic thromboembolic pulmonary hypertension and less severe disease. Thorax, Vol. 77(Suppl 1) (pp a58-a59). Westminster, London, United Kingdom, 23 November 2022 - 23 November 2022. View this article in WRRO
• Middleton JT, Binmahfooz S, Zafar H, Patel J, Giri D, Battersby C, Toshner M, Reddy A, Lewis R, Condliffe R , Elliot C et al (2022) Abstract 13553: Remote Monitoring of the Haemodynamic Response to Clinically Indicated Therapeutic Escalation and Clinical Worsening Events in Patients With Pulmonary Arterial Hypertension. Circulation, Vol. 146(Suppl_1)
• Middleton JT, Binmahfooz S, Zafar H, Patel J, Neelam Naganathan DG, Battersby C, Toshner M, Reddy A, Lewis R, Swift AJ , Condliffe R et al (2022) Abstract 13527: The Development of a Remote Pulmonary Arterial Hypertension Risk Score Utilising Remote Monitoring Technology to Monitor Parameters Associated With Mortality in Pulmonary Arterial Hypertension. Circulation, Vol. 146(Suppl_1)
• Sharkey MJ, Karunasaagarar K, Johns C, Rajaram S, Alkhanfar D, Dwivedi K, Alabed S, Metherall P, Van Der Geest R, Mamalakis M , Kiely D et al (2022) Fully Automatic Cardiac and Great Vessel Segmentation on CT Pulmonary Angiography (CTPA) Using Deep Learning. D106. NOE VALLEY: CLOTS, COVID, AND LUNG VASCULAR DISEASES
• Alandejani F, Alabed S, Garg P, Goh ZM, Karunasaagarar K, Sharkey M, Salehi M, Aldabbagh Z, Dwivedi K, Metherall P , Uthoff J et al (2022) Training and clinical validation of artificial intelligence derived right atrial cardiovascular magnetic resonance measurements. American Journal of Respiratory and Critical Care Medicine, Vol. 205 (pp a2285-a2285). American Thoracic Society 2022 International Conference, 13 May 2022 - 13 May 2022. View this article in WRRO
• Mamalakis M, Dwivedi K, Sharkey M, Alabed S, Metherall P, Kiely D & Swift A (2022) Deep Learning Approaches to Classify Lung Parenchymal Disease on CT Images. D106. NOE VALLEY: CLOTS, COVID, AND LUNG VASCULAR DISEASES
• Dwivedi K, Lewis R, Condliffe R, Sharkey MJ, Mamalakis M, Alabed S, Wild JM, Swift AJ & Kiely D (2022) Computed Tomography (CT) features are of diagnostic utility in pre diagnosis Idiopathic Pulmonary Arterial Hypertension (IPAH): a case controlled study. American Journal of Respiratory and Critical Care Medicine, Vol. 205 (pp a3605-a3605). San Francisco, CA, 13 May 2022 - 13 May 2022. View this article in WRRO
• Kariotis S, Jammeh E, Swietlik EM, Rhodes CJ, Errington N, Thompson R, Wharton J, Coghlan G, Lordan J, Corris P , Howard LS et al (2022) Longitudinal Analysis of Three Major Risk-Associated Transcriptomic Subgroups Within the IPAH Classification. C55. NOB HILL: CELLULAR ORIGINS OF PULMONARY VASCULAR DISEASE
• Humbert M, Dreyer N, Mclaughlin V, Pulido T, Boyanova N, Frauchiger B, Kiefer F, Lassen C, Ong R, Sanna L , Sauter A et al (2022) CARE PAH study design: an international, prospective real-world cohort of PAH patients. EUROPEAN RESPIRATORY JOURNAL, Vol. 60
• Middleton JT, Binmahfooz S, Zafar H, Patel J, Giri D, Battersby C, Toshner M, Reddy A, Lewis R, Condliffe R , Elliot C et al (2022) Remote Monitoring of the Haemodynamic Response to Clinically Indicated Therapeutic Escalation and Clinical Worsening Events in Patients With Pulmonary Arterial Hypertension. CIRCULATION, Vol. 146
• Middleton JT, Binmahfooz S, Zafar H, Patel J, Naganathan DGN, Battersby C, Toshner M, Reddy A, Lewis R, Swift AJ , Condliffe R et al (2022) The Development of a Remote Pulmonary Arterial Hypertension Risk Score Utilising Remote Monitoring Technology to Monitor Parameters Associated With Mortality in Pulmonary Arterial Hypertension. CIRCULATION, Vol. 146
• Barbera JA, Kiely D, Gruenig E, Balasubramanian V, Vizza CD, Elwing J, Sood N, Rao Y, Holdstock L, Seaman S , Broderick M et al (2022) Efficacy and dose-response relationship of oral treprostinil in PAH patients on monotherapy or dual background therapy. EUROPEAN HEART JOURNAL, Vol. 43 (pp 1920-1920)
• Karia N, Howard L, Johnson M, Kiely D, Lordan J, McCabe C, Ong R, Pepke-Zabe J, Preiss M, Muthurangu V & Coghlan G (2022) Mortality rates and cause of mortality in patients with mildly elevated pulmonary pressures versus PH: insights from the retrospective EVIDENCE-PAH study. EUROPEAN HEART JOURNAL, Vol. 43 (pp 1927-1927)
• Alabed S, Karunasaagarar K, Alandejani F, Salehi M, Aldabbagh Z, Garg P, Uthoff J, Lu H, Wild J, Kiely D , Van Der Geest R et al (2021) A fully automated cardiac magnetic resonance (CMR) assessment improves the evaluation of patients with pulmonary arterial hypertension (PAH). Imaging
• Saunders L, Capener D, Condliffe R, Kiely D, Wild J & Swift A (2021) MRI metric lung parenchyma T1 indicates lung pathology in patients with pulmonary hypertension. Pulmonary hypertension
• Condliffe R, Bauchmuller K, Southern J, Billings C, Charalampopoulos A, Elliot C, Hameed A, Kiely D, Sabroe I, Thompson R , Raithatha A et al (2021) Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry. Pulmonary hypertension
• Armstrong I, Billings C, Clayton S, Kiely DG, Sephton JP, Smith J & Ferguson M (2021) The lived experiences of people shielding with pulmonary hypertension during the first wave of the COVID-19 pandemic. Pulmonary hypertension
• Sammut MA, Condliffe R, Hameed A, Rothman AM, Kyriacou A, Lewis RA, Durrington C, Elliot CA, Thompson AA, Sabroe I , Kiely DG et al (2021) Abstract 13581: Heart Rhythm versus Heart Rate Control Strategy in Patients With Pre-Capillary Pulmonary Hypertension and Atrial Arrhythmias. Circulation, Vol. 144(Suppl_1)
• Gosling R, Alabed S, Swoboda P, Nagueh SF, Jones R, Rothman A, Wild JM, Kiely DG, Condliffe R, Swift AJ & Garg P (2021) 19 Cardiac magnetic resonance to identify raised left ventricular filling pressure. Heart, Vol. 107(Suppl 3) (pp a17-a18). Virtual conference, 12 October 2021 - 12 October 2021. View this article in WRRO
• Middleton J, Zafar H, Kiely DG & Rothman A (2021) 124 Comparing the safety and feasibility of implanting pulmonary artery pressure monitors via the internal jugular vein compared to standard femoral venous access in patients with pulmonary arterial hypertension. Heart failure
• Middleton J, Zafar H, Reddy A, Martin C, Thompson R, Swift A, Toshner M, Kiely DG & Rothman A (2021) 121 Effect of UK COVID-19 public health measures on activity and quality of life in patients with pulmonary arterial hypertension. Heart failure
• Kiely DG, Cottreel E, Galiè N, Marcus JT, Peacock A, Rosenkranz S, Swift AJ, Tawakol A, Torbicki A, Vonk Noordegraaf A , Wetherill G et al (2021) S93 REPAIR: long-term effects of macitentan on the right ventricle (RV) in pulmonary arterial hypertension (PAH). Pulmonary arterial hypertension: drugs, sox and cytokines
• Maranthe N, Austin M, Billings C, Elliot C, Charalampopoulos A, Hameed A, Hamilton N, Kiely DG, Lewis R, Sabroe I , Smith I et al (2021) P140 Comparison of different measures of diffusion capacity in suspected systemic sclerosis associated pulmonary arterial hypertension. The nuts and bolts of ILD clinical management
• Sammut MA, Condliffe R, Hameed A, Rothman AM, Kyriacou A, Lewis RA, Durrington C, Elliot CA, Thompson AA, Sabroe I & Kiely DG (2021) Heart Rhythm versus Heart Rate Control Strategy in Patients With Pre-Capillary Pulmonary Hypertension and Atrial Arrhythmias. CIRCULATION, Vol. 144
• Middleton JT, Konganige S, Dahaghin P, Zafar H, Reddy A, Martin C, Thompson AAR, Swift AJ, Morris P, Condliffe R , Morrell NW et al (2020) Abstract 15636: Effect of COVID-19 Public Health Measures on Activity and Quality of Life in Patients With Pulmonary Arterial Hypertension. Circulation, Vol. 142(Suppl_3) View this article in WRRO
• Hughes P, Swift A, Wilson F, Cogliano M, Alandejani F, Cahn A, Kendall L, Kiely D & Wild J (2020) Lung perfusion in pulmonary hypertension – results from the RESPIRE study. Pulmonary hypertension
• Kiely D, Cottreel E, Galiè N, Marcus JT, Peacock A, Rosenkranz S, Swift AJ, Tawakol A, Torbicki A, Vonk Noordegraaf A , Wetherill G et al (2020) REPAIR: long-term effects of macitentan on the right ventricle (RV) in pulmonary arterial hypertension (PAH). Pulmonary hypertension
• Keen C, Harrop D, Kiely DG, Hashmi-Greenwood M & Sage K (2020) Outcomes measures used in studies of exercise rehabilitation in pulmonary hypertension: a systematic review. Physiotherapists
• Howard L, Chin K, Fong Y-L, Gargano C, Stamatiadis D, Maron B, Preston I, Quinn D, Rosenkranz S, Toshner M , Wilkins M et al (2020) CIPHER: a prospective, multicentre study for the identification of biomarker signatures for early detection of pulmonary hypertension. Pulmonary hypertension
• Alandejani F, Tubman E, Shahin Y, Lewis R, Dwivedi K, Alkhanfar D, Alabed S, Johns C, Garg P, Condliffe R , Lawrie A et al (2020) Cardiac MRI right atrial area measurement thresholds for risk stratification in patients with PAH. Pulmonary hypertension
• Lewis RA, Kelly T, Drew E, Billings CG, Hurdman J, Smith I, Austin M, Armstrong IJ, Middleton J, Rothman AMK , Harrington J et al (2020) Percent-predicted incremental shuttle walking test distance stratifies risk in pulmonary arterial hypertension. Pulmonary hypertension
• Uthoff J, Alabed S, Garg P, Lawrie A, Wild JM, Kiely DG, Lu H & Swift AJ (2020) Sex bias exists in diagnosing pulmonary arterial hypertension via machine learning. Pulmonary hypertension
• Lewis R, Armstrong I, Bergbaum C, Brewis MJ, Cannon J, Charalampopoulos A, Church AC, Coghlan JG, Davies R, Dimopoulos K , Elliot C et al (2020) EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multi-centre study. Pulmonary hypertension
• Lewis RA, Thompson AAR, Billings CG, Charalampopoulos A, Elliot C, Hamilton N, Hill C, Hurdman J, Rajaram S, Sabroe I , Swift AJ et al (2020) Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension. Pulmonary hypertension
• Alabed S, Alandejani F, Shahin Y, Wild J, Kiely D & Swift A (2020) Cardiac MRI for Prognosis in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis. Imaging
• Alkhanfar D, Shahin Y, Alandejani F, Alabed S, Johns C, Mk Rothman A, Garg P, Condliffe R, Quadery R, Kiely DG , Wild J et al (2020) Serial cardiac MRI for assessment of cardiac morphology and function in CTEPH patients after PEA or vasodilator therapy. Pulmonary hypertension
• Price L, Brame A, Martinez G, Mukerjee B, Harries C, Kempny A, Marino P, Church C, Johnson M, Condliffe R , Kiely D et al (2020) Perioperative management of patients with Pulmonary Hypertension undergoing Non-Cardiac Surgery: A Systemic Review and UK Consensus Statement. Pulmonary hypertension
• Otero-Núñez P, Rhodes C, Wharton J, Swietlik E, Kariotis S, Harbaum L, Dunning M, Elinoff J, Errington N, Thomson R , Iremonger J et al (2020) Multi-omic profiling in pulmonary arterial hypertension. Pulmonary hypertension
• Omura J, Habbout K, Shimauchi T, Breuils-Bonnet S, Tremblay E, Martineau S, Nadeau V, Potus F, Archer SL, Lin J , Zafar H et al (2020) Identification of Circulating Long Non-Coding RNA H19 as a Novel Biomarker for Right Ventricular Failure Associated with Pulmonary Arterial Hypertension. C105. WITH ALL MY HEART: SEX, ESTROGEN, AND RIGHT VENTRICLE IN PULMONARY VASCULAR DISEASE AND BEYOND
• Rothman A, Vachiery J-LE, Howard LS, Mikhail G, Lang IM, Jonas M, Kiely DG, Abriel A, Lewis GD, Rosenzweig EB , Kirtane AJ et al (2020) Percutaneous Endovascular Ultrasound Pulmonary Artery Denervation for the Treatment of Pulmonary Arterial Hypertension: 12-Month Results of the Trophy 1 Study. D63. PULMONARY EMBOLISM: CASE REPORTS AND LATE BREAKING
• Omura J, Habbout K, Shimauchi T, Breuils-Bonnet S, Tremblay E, Martineau S, Nadeau V, Potus F, Archer SL, Lin J , Zafar H et al (2020) Long Non-Coding RNA H19 Promotes Right Ventricular Failure in PAH. A93. TRANSLATIONAL RESEARCH; EARLY CLINICAL FINDINGS AND OMICS ADVENTURE IN PULMONARY HYPERTENSION: FROM BIOMARKERS TO NEW THERAPEUTIC TARGETS
• Bunclark K, Liley J, Newnham M, Ruggiero A, Cannon JE, Coghlan G, Lordan J, Howard L, Jenkins D, Johnson M , Kiely DG et al (2019) P117 Machine learning tool provides new insights into risk assessment in pulmonary endarterectomy. Pulmonary hypertension: advances in diagnosis and treatment
• Babu A, Ruggiero A, Cannon JE, Coghlan G, Lordan J, Howard L, Jenkins D, Johnson M, Kiely DG, Ng C , Screaton N et al (2019) P119 Evolving surgical expertise and patient choice in pulmonary endarterectomy. Pulmonary hypertension: advances in diagnosis and treatment
• Howard L, He J-G, Wharton J, Watson G, Gall H, Ghofrani H, Huang L, Kiely D, Luo Q, Sheares K , Zhao L et al (2019) Late Breaking Abstract - Supplementation of iron in pulmonary hypertension (SIPHON): results from a randomised controlled crossover trial. Right ventricle
• Kiely D, Rosenkranz S, Galiè N, Channick R, Cottreel E, Martin N, Peacock A, Tawakol A, Torbicki A & Vonk Noordegraaf A (2019) P116 Effects of macitentan on right ventricular remodeling in pulmonary arterial hypertension – results from the REPAIR study interim analysis. Pulmonary hypertension: advances in diagnosis and treatment
• Kiely D, Swift A, Cogliano M, Kendall L, Oram C, Capener D, Rothman A, Garg P, Johns C, Austin M , Pickworth J et al (2019) A prospective study comparing the repeatability and sensitivity to change of non-invasive endpoints in pulmonary arterial hypertension: the RESPIRE study. Pulmonary hypertension
• Dwivedi K, Johns C, Goh ZM, Rajaram S, Hill C, Karunasaagarar K, Currie B, Chin M, Condliffe R, Kiely D & Swift A (2019) CT pulmonary angiography-derived right atrial area can risk stratify patients with PAH and PH. Imaging
• Swift A, Cogliano M, Oram C, Kendall L, Capener D, Garg P, Johns C, Macdonald A, Wilson F, Cahn T , Lawrie A et al (2019) Repeatability and Sensitivity to change of right ventricular analysis methods using cardiac magnetic resonance imaging in PAH: results from the RESPIRE Study. Imaging
• Cogliano M, Lawrie A, Kiely DG, Condliffe RA, Rajaram S, Screaton N, Hadinnapola C, Swietlik EM, Gräf S, Howard LS , Coghlan G et al (2019) Thoracic CT features of patients with BMPR2 mutation: preliminary analysis from the UK National Cohort Study of Idiopathic and Heritable PAH. Pulmonary hypertension
• Ramjug S, Billings C, Bowater S, Charalampopoulos A, Clift P, Elliot C, Hurdman J, Jenkins P, Kiely D, Lewis R , Oliver J et al (2019) Risk stratification of pulmonary arterial hypertension (PAH) associated with adult congenital heart disease (ACHD). Pulmonary hypertension
• Swift A, Johns C, Chin M, Currie B, Elliot C, Charalampopolous T, Sabroe I, Dwivedi K, Rajaram S, Hill C , Wild J et al (2019) Diagnostic and prognostic value of a diagnostic CT regression model in suspected pulmonary hypertension. Pulmonary hypertension
• Macdonald A, Johns C, Garg P, Cogliano M, Condliffe R, Wild J, Kiely D & Swift A (2019) Diagnostic accuracy of right ventricular trabecular mass measurements as measured on cardiac MRI in suspected pulmonary hypertension. Pulmonary hypertension
• Fidock B, Balasubramanian N, Barker N, Macdonald A, Capener D, Johns C, Karunasaagarar K, Fent G, Al-Mohammad A, Rothman A , Kiely D et al (2019) 284An accurate, multi-parametric cardiovascular magnetic resonance model to predict mean pulmonary artery pressure in pulmonary hypertension. European Heart Journal - Cardiovascular Imaging, Vol. 20(Supplement_2) View this article in WRRO
• Barker N, Fidock B, Balasubramanian N, Macdonald AW, Capener D, Johns CS, Karunasaagarar K, Fent G, Al-Mohammad A, Rothman A , Kiely DG et al (2019) P165A novel cardiac magnetic resonance imaging model to predict level of mixed venous oxygen levels in pulmonary hypertension. European Heart Journal - Cardiovascular Imaging, Vol. 20(Supplement_2) View this article in WRRO
• Balasubramanian N, Baker N, Fidock B, Macdonald AW, Capener D, Johns CS, Karunasaagarar K, Fent G, Al-Mohammad A, Rothman A , Kiely DG et al (2019) P612Averaged, diastolic mitral inflow velocity mapping versus peak velocity for the assessment of left ventricular haemodynamics. European Heart Journal - Cardiovascular Imaging, Vol. 20(Supplement_2) View this article in WRRO
• Bunclark K, Newnham M, Chiu Y-D, Ruggiero A, Villar S, Cannon J, Coghlan G, Corris PA, Howard L, Jenkins D , Johnson M et al (2019) A Multicentre Study of Anticoagulation in Operable Chronic Thromboembolic Pulmonary Hypertension. A56. SYMPATHY FOR THE CLOT: UPDATE ON PULMONARY EMBOLISM AND CTEPH
• Lewis R, Billings C, Hurdman J, Smith I, Austin M, Armstrong I, Swift A, Rothman A, Charalampopoulos A, Sabroe I , Elliot C et al (2019) The Incremental Shuttle Walking Test Can Be Used to Risk Stratify Patients with Pulmonary Hypertension as Per the European Respiratory/Cardiac Society Guidelines. A105. GLORY DAYS: THE LATEST CLINICAL RESEARCH IN PAH
• Lewis R, Cogliano M, Johns CS, Billings CG, Hamilton N, Elliot CA, Charalampopoulos A, Sabroe I, Thompson R, Condliffe R , Wild JM et al (2019) Cardiac MRI: Identifying Thresholds to Predict Mortality in Pulmonary Arterial Hypertension. B27. HEARTBREAKER: HEART FAILURE AND PULMONARY HYPERTENSION
• Barker N, Fidock B, Balasubramanian N, Macdonald AW, Capener D, Johns CS, Karunasaagarar K, Fent G, Al-Mohammad A, Rothman A , Kiely DG et al (2019) A novel cardiac magnetic resonance imaging model to predict level of mixed venous oxygen levels in pulmonary hypertension. EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, Vol. 20 (pp 121-121)
• Balasubramanian N, Baker N, Fidock B, Macdonald AW, Capener D, Johns CS, Karunasaagarar K, Fent G, Al-Mohammad A, Rothman A , Kiely DG et al (2019) Averaged, diastolic mitral inflow velocity mapping versus peak velocity for the assessment of left ventricular haemodynamics. EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, Vol. 20 (pp 494-495)
• Lewis R, Billings C, Johns C, Hurdman J, Hamilton N, Elliot C, Charalampopoulos A, Sabroe I, Wild J, Swift A , Kiely D et al (2018) P16 Identifying partial anomalous pulmonary venous drainage (PAPVD) in patients presenting with suspected pulmonary hypertension (PH). Under pressure: an update in pulmonary vascular disease
• Swietlik EM, Hodgson J, Hadinnapola C, Bleda M, Haimel M, Church C, Coghlan G, Condliffe R, Corris PA, Gibbs JSR , Holden S et al (2018) S40 Phenotypic characterisation of GDF2 mutation carriers in a large cohort of patients with pulmonary arterial hypertension. Fundamental mechanisms of pulmonary arterial hypertension
• Keen C, Armstrong I & Kiely DG (2018) P18 Community-based pulmonary rehabilitation in patients with pulmonary hypertension: a feasibility study. Under pressure: an update in pulmonary vascular disease
• Lin J, Iremonger J, Pickworth J, Rothman A, Casbolt H, Arnold N, Elliot C, Condliffe R, Kiely D, Jing ZC & Lawrie A (2018) S43 Circulatory levels of microrna-34a expression identify patients with poor clinical outcome, and regulate pulmonary vascular cell phenotype. Fundamental mechanisms of pulmonary arterial hypertension
• Armstrong I, Billings C, Clayton S, Yorke J, Harries C & Kiely D (2018) Assessing the financial impact of pulmonary hypertension: a survey by the UK Pulmonary Hypertension Association (PHA-UK). Pulmonary hypertension
• Kiely D, Lawrie A, Doyle O, Salvatelli V, Daniels F, Drage E, Jenner H, Rigg J, Schmitt C, Samyshkin Y & Bergemann R (2018) Real world data from hospital episode statistics can be used to determine patients at risk of idiopathic pulmonary arterial hypertension. Pulmonary hypertension
• Lewis R, Billings C, Johns C, Hurdman J, Hamilton N, Elliot C, Charalampopoulos A, Sabroe I, Wild J, Swift A , Kiely D et al (2018) Anomalous pulmonary venous drainage (APVD) in patients with suspected pulmonary hypertension (PH). Pulmonary hypertension
• Ming M, Nair A, Saunders S, Condliffe R, Elliot C, Charalampopoulos A, Sabroe I, Lewis R, Armstrong I, Sephton P , Hamilton N et al (2018) Good outcomes following elective lower limb orthopaedic surgery in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Pulmonary hypertension
• Billings C, Lewis R, Armstrong I, Hurdman J, Smith I, Austin M, Elliot C, Charalampopoulos A, Sabroe I, Lawrie A , Thompson R et al (2018) Incremental shuttle walking test distance is reduced in patients with pulmonary hypertension in WHO Functional Class I. Pulmonary hypertension
• Billings C, Lewis R, Hurdman J, Armstrong I, Smith I, Austin M, Elliot C, Charalampopoulos A, Sabroe I, Lawrie A , Thompson R et al (2018) Incremental Shuttle Walk Test predicts survival in non-Group 1 Pulmonary Hypertension without a ceiling effect. Pulmonary hypertension
• Saunders L, Johns CS, Stewart N, Capener D, Kiely D, Graves M, Wild JM & Swift A (2018) Prognostic Value of T1 Mapping in Pulmonary Arterial Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 197
• Toshner M, Church A, Harlow L, Coghlan G, Gibbs S, Gor D, Hernandez-Sanchez J, Kiely D, Knightbridge E, Suntharalingam J , Wilkins M et al (2018) Transform-UK: A Phase 2 Trial of Tocilizumab in Pulmonary Arterial Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 197
• Saunders L, Johns CS, Stewart N, Capener D, Kiely D, Graves M, Wild JM & Swift A (2018) Diastolic Septal Angle Is an Independent Predictor of Right Ventricular Insertion Point T1 in Pulmonary Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 197
• Swift A, Johns CS, Julius T, Goh Z, Barnes S, Elliot C, Charalampopolous A, Wild JM, Hill C, Condliffe RA & Kiely D (2018) Diagnostic Accuracy and Reproducibility of Unenhanced Computed Tomography in Suspected Pulmonary Hypertension: Pulmonary Arterial and Cardiac Metrics. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 197
• Gruenig E, Barbera JA, Benjamin N, Blanco I, Bossone E, Cittadini A, Coghlan G, Corris P, D'Alto M, D'Andrea A , Delcroix M et al (2018) European Respiratory Society Task Force: Exercise Training and Rehabilitation in Patients with Severe Chronic Pulmonary Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 197
• Johns CS, Wild JM, Garg P, Sowden C, Mahmoud I, Rajaram S, Elliot C, Condliffe RA, Charalampopoulos A, Kiely D & Swift A (2018) Cardiac MRI Measured Left Atrial Function Can Identify Patient with Pulmonary Hypertension Due to Left Heart Disease. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 197
• Bergemann R, Allsopp J, Jenner H, Daniels FA, Drage E, Samyshkin Y, Schmitt C, Kiely D & Lawrie A (2018) Development of a Predictive Algorithm Based on Healthcare Behaviour to Support Earlier Diagnosis of Idiopathic Pulmonary Arterial Hypertension: Results of a Feasibility Study in the UK. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 197
• Lewis R, Dwivedi K, Kyriacou A, Elliot C, Condliffe R, Sabroe I, Swift A, Kiely DG & Charalampopoulos A (2018) Sinus Rhythm Restoration is Safe and Leads to Clinical Improvement in Patients With Severe Pulmonary Hypertension.. CIRCULATION, Vol. 138
• Johns CS, Wild JM, Rajaram S, Tubman E, Capener D, Elliot C, Condliffe R, Charalampopoulos A, Kiely DG & Swift AJ (2017) Septal angle on MRI predicts combined pre and post capillary pulmonary hypertension. Thorax, Vol. 72(Suppl 3) (pp A31-A32), 6 December 2017 - 8 December 2017. View this article in WRRO
• Klooster LT, Wilson V, Selby K, Newton R, Gandhi S, Bonnet T, Fletcher J, Armstrong I, Martin L, Hamilton N , Mills G et al (2017) P180 Managing pregnancy in pulmonary hypertension using a multi-professional approach: a 16-year experience in a specialist referral centre. Pulmonary vascular disease: monitoring and managing
• Newnham M, Toshner M, Bleda M, Auger WR, Barberà JA, Bogaard HJ, Cannon J, Coghlan G, Corris PA, Delcroix M , Dunning J et al (2017) S108 Genome-wide association study in chronic thromboembolic pulmonary hypertension reveals new insights into aetiology. Advances in understanding chronic thrombo-embolic disease and pulmonary hypertension
• Quadery SR, Swift AJ, Billings C, Thompson AAR, Elliot CA, Hurdman J, Garrod S, Charalampopolous A, Sabroe I, Armstrong I , Hamilton N et al (2017) P183 Impact of patient choice on survival in patients with chronic thromboembolic pulmonary hypertension offered pulmonary endarterectomy. Pulmonary vascular disease: monitoring and managing
• Currie B, Johns C, Chin M, Elliot CA, Condliffe RA, Charalampopolous A, Rajaram S, Wild JM, Kiely DG & Swift AJ (2017) S52 Computed tomography in the diagnosis of left heart disease in patients with suspected pulmonary hypertension. Diagnosing and treating pulmonary vascular disease
• Swift AJ, Chin M, Currie B, Elliot CA, Charalampopolous A, Rajaram S, Wild JM, Johns C & Kiely DG (2017) P177 Computed tomography diagnostic model for diagnosis of pulmonary hypertension. Pulmonary vascular disease: monitoring and managing
• Dirir O, Lodge KM, Creaser-Myers A, Walker S, Kiely DG, Condliffe AM, Lawrie A & Thompson AAR (2017) S111 Altered neutrophil phenotypes in pulmonary arterial hypertension. Advances in understanding chronic thrombo-embolic disease and pulmonary hypertension
• Arnold ND, Pickworth JA, Carvalho JA, Braithwaite AT, Iremonger J, West L, Casbolt HL, Renshall LJ, Germaschewski V, McCourt M , Evans HR et al (2017) Development of a Novel Human Anti-OPG Antibody That Attenuates Experimental Pulmonary Arterial Hypertension. CIRCULATION, Vol. 136
• ten Klooster L, Theodorou C, Wilson V, Selby K, Newton R, Gandhi S, Bonnett T, Fletcher J, Armstrong I, Martin L , Hamilton N et al (2017) Managing pregnancy in pulmonary hypertension using a multi-professional approach: a 16-year experience in a specialist referral centre. Pulmonary Circulation and Pulmonary Vascular Disease
• Hawes R, Wilson V, Newton R, Ten Klooster L, Kiely D, Condliffe R, Elliot C & Gandhi S (2017) Safe delivery of parturients with pulmonary hypertension: 16 years' experience in a national specialist referral centre. ANAESTHESIA, Vol. 72 (pp 56-56)
• Lungu A, Hose DR, Kiely DG, Capener D, Wild JM & Swift AJ (2017) Three Element Windkessel Model to Non-Invasively Assess PAH Patients: One Year Follow-up (pp 151-154)
• Bohnen MS, Ma L, Zhu N, Qi H, McClenaghan C, Gonzaga-Jauregui C, Dewey FE, Overton JD, Reid JG, Shuldiner AR , Baras A et al (2017) Loss of Function ABCC8 Mutations Are Associated With Pulmonary Arterial Hypertension. CIRCULATION, Vol. 136
• Hadinnapola C, Haimel M, Bleda M, Bogaard H, Coghlan G, Corris P, Gibbs S, Kiely D, Lawrie A, Peacock A , Pepke-Zaba J et al (2016) S107 Genotype-phenotype associations in pulmonary arterial hypertension caused by BMPR2 and EIF2AK4 variants. Thorax, Vol. 71(Suppl 3) (pp A63-A64)
• Johns CS, Capener D, Hammerton C, Shotton K, Kiely DG, Wild JM & Swift AJ (2016) Non-invasive methods for the estimation of MPAP in COPD patients using cardiac MRI. Thorax, Vol. 71(Suppl 3) (pp A106-A107), 7 December 2016 - 9 December 2016. View this article in WRRO
• Lin J, Iremonger J, Pickworth J, Rothman A, Casbolt H, Arnold N, Elliot C, Condliffe R, Kiely D & Lawrie A (2016) P245 Whole blood levels of microrna-34a predict survival and regulate genes associated with pulmonary arterial hypertension. Thorax, Vol. 71(Suppl 3) (pp A220.2-A221)
• Quadery SR, Condliffe RA, Billings C, Thompson R, Elliot CA, Charalampopolous A, Hurdman J, Hamilton N, Armstrong I, Sephton P , Sabroe I et al (2016) P28 Chronic thromboembolic pulmonary hypertension: long term outcomes in surgical and non-surgical patients. Thorax, Vol. 71(Suppl 3) (pp A98.1-A98)
• Ramjug S, Hussain N, Hurdman J, Billings C, Elliot CA, Kiely DG, Sabroe I, Rajaram S, Swift AJ & Condliffe R (2016) S111 Differences in characteristics and outcomes in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. Thorax, Vol. 71(Suppl 3) (pp A66-A67)
• Lungu A, Hose R, Capener D, Kiely D, Wild J & Swift A (2016) Response to treatment assessment in patients with PAH by MRI based computational modelling. 4.3 Pulmonary Circulation and Pulmonary Vascular Diseases
• Ramjug S, Hussein N, Billings C, Charalampopoulos A, Elliot C, Kiely D, Lawrie A, Rajaram S, Swift A, Wild J & Condliffe R (2016) Idiopathic and systemic sclerosis-associated PAH: A comprehensive haemodynamic and radiological comparison. 4.3 Pulmonary Circulation and Pulmonary Vascular Diseases
• Ramjug S, Hussain N, Billings C, Charalampopoulos A, Elliot C, Kiely D, Hurdman J, Smith I & Condliffe R (2016) Gas transfer measurement in systemic sclerosis associated pulmonary hypertension. 4.3 Pulmonary Circulation and Pulmonary Vascular Diseases
• Swift A, Lungu A, Capener D, Hammerton C, Rothman A, Lawrie A, Elliot C, Condliffe R, Kiely D & Wild J (2016) Age is independently associated with pulmonary arterial compliance in health and in patients with pulmonary vascular disease. 4.3 Pulmonary Circulation and Pulmonary Vascular Diseases
• Tubman E, Sproson T, Capener D, Condliffe R, Elliot C, Charalampopolous A, Kiely D, Wild J & Swift A (2016) Change in right atrial minimal volume is a prognostic marker in pulmonary arterial hypertension (PAH). 1.3 Imaging
• Ramjug S, Hussain N, Billings C, Charalampopoulos A, Elliot C, Kiely D, Hurdman J, Smith I & Condliffe R (2016) Gas transfer measurement in systemic sclerosis associated pulmonary hypertension. EUROPEAN RESPIRATORY JOURNAL, Vol. 48
• Swift A, Lungu A, Capener D, Hammerton C, Rothman A, Lawrie A, Elliot C, Condliffe R, Kiely D & Wild J (2016) Age is independently associated with pulmonary arterial compliance in health and in patients with pulmonary vascular disease. EUROPEAN RESPIRATORY JOURNAL, Vol. 48
• Ramjug S, Hussein N, Billings C, Charalampopoulos A, Elliot C, Kiely D, Lawrie A, Rajaram S, Swift A, Wild J & Condliffe R (2016) Idiopathic and systemic sclerosis-associated PAH: A comprehensive haemodynamic and radiological comparison. EUROPEAN RESPIRATORY JOURNAL, Vol. 48
• Tubman E, Sproson T, Capener D, Condliffe R, Elliot C, Charalampopolous A, Kiely D, Jim W & Swift A (2016) MRI derived left atrial volume index predicts treatment response in patients with PAH. 4.3 Pulmonary Circulation and Pulmonary Vascular Diseases
• Quadery S, Billings C, Wild J, Swift A, Rajaram S, Davies C, Hill C, Thomas S, Braidley P, Hunter S , Armstrong I et al (2016) Chronic thrombo-embolic pulmonary hypertension: Long-term outcomes in operated and non-operated patients. 4.3 Pulmonary Circulation and Pulmonary Vascular Diseases
• Hadinnapola C, Bleda M, Haimel M, Bogaard HJ, Coghlan G, Corris PA, Gibbs JS, Kiely DG, Lawrie A, Peacock AJ , Machado RD et al (2016) Utility Of Deep Phenotyping In The Identification And Validation Of Novel Causal Whole Genome Sequencing Variation In Patients With Pulmonary Arterial Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 193
• Graf S, Bleda M, Hadinnapola C, Haimel M, Bogaard HJ, Coghlan G, Corris PA, Gibbs JS, Kiely DG, Lawrie A , Machado RD et al (2016) Whole Genome Sequencing In Idiopathic And Heritable Pulmonary Arterial Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 193
• Treacy C, Blenda M, Hadinnapola C, Haimel M, Coghlan G, Corris PA, Gibbs JS, Kiely DG, Lawrie A, Peacock AJ , Pepke-Zaba J et al (2016) The Uk National Cohort Study Of Idiopathic And Heritable Pulmonary Arterial Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 193
• Smith I, Billings C, Kiely D, Yorke J & Armstrong I (2016) Extended Evaluation Of Emphasis-10 Quality Of Life Questionnaire In Ph. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 193
• Iremonger J, Rothman AM, Rhodes C, Condliffe R, Elliot CA, Kiely D, Howard LS, Gibbs S, Wharton J, Wilkins MR & Lawrie A (2016) Investigating The Diagnostic Potential Of Circulating Mirna Signatures In Pulmonary Arterial Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 193
• Rhodes C, Wharton J, Ghataorhe P, Watson G, Girerd B, Howard LS, Gibbs S, Condliffe R, Elliot CA, Kiely D , Simonneau G et al (2016) Plasma Proteome Analysis In Idiopathic Pulmonary Arterial Hypertension Identifies A Panel Of Prognostic Proteins. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 193
• Toshner M, Bleda M, Newnham M, Lang I, Delcroix M, Cannon J, Sheares K, Coghlan G, Corris PA, Gibbs S , Kiely D et al (2016) Genome Wide Association Studies In Chronic Thromboembolic Pulmonary Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 193
• Thompson AAR, Arnold ND, Braithwaite AT, Casbolt HL, Pickworth JA, Cole JE, Monaco C, Kiely D, Sabroe I & Lawrie A (2016) Deficiency Of Toll-Like Receptor 3 (tlr3) Exacerbates Pulmonary Hypertension In Mice. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 193
• Lungu A, Hose R, Capener D, Kiely D, Wild J & Swift A (2016) Response to treatment assessment in patients with PAH by MRI based computational modelling. EUROPEAN RESPIRATORY JOURNAL, Vol. 48
• Stewart NJ, Norquay G, Parra-Robles J, Marshall H, Leung G, Murphy PS, Schulte RF, Elliot CA, Condliffe R, Billings CG , Smith I et al (2015) Assessment of lung microstructure in ILD with3He and129Xe MRI. 4.1 Clinical respiratory physiology, exercise and functional imaging
• Hamilton N, Sellars M, Graves M, Armstrong I, Charalampopolous A, Kiely D, Elliot C & Condliffe R (2015) Macitentan for pulmonary arterial hypertension (PAH): Early clinical experience of 94 patients. 4.3 Pulmonary Circulation and Pulmonary Vascular Disease
• Swift A, Lungu A, Walker H, Capener D, Hammerton C, Elliot C, Condliffe R, Kiely D & Wild J (2015) Estimation of mPAP with MRI in pulmonary hypertension subgroups: Comparison with echocardiography. 4.3 Pulmonary Circulation and Pulmonary Vascular Disease
• Swift A, Lungu A, Walker H, Capener D, Hammerton C, Elliot C, Condliffe R, Kiely D & Wild J (2015) Improved diagnostic accuracy of MRI in patients with suspected pulmonary hypertension with combined right ventricle and pulmonary artery metrics. 4.3 Pulmonary Circulation and Pulmonary Vascular Disease
• Lungu A, Swift A, Capener D, Kiely D, Hose R & Wild J (2015) Diagnosis of pulmonary hypertension from MR image based computational models of pulmonary vascular haemodynamics and decision tree analysis. 4.3 Pulmonary Circulation and Pulmonary Vascular Disease
• Hutchison L, Stewart N, Hughes P, Hammerton C, Graves M, Kiely D, Wild J & Swift A (2015) Myocardial T1 mapping MRI in patients with PH and age-matched healthy volunteers. 4.3 Pulmonary Circulation and Pulmonary Vascular Disease
• Carter S, Jutley G, Kiely D, Condliffe R, Renshaw S, Whyte M, Kuet K, Kilding R & Akil M (2015) SAT0477 Rituximab Treatment for Connective Tissue Disease Associated Interstitial Lung Disease: A Retrospective Case Series. Annals of the Rheumatic Diseases, Vol. 74(Suppl 2) (pp 833.1-833)
• Billings C, Hurdman J, Austin M, Armstrong I, Elliot C, Condliffe R & Kiely D (2014) P170 Heart Rate Recovery At One Minute Following Incremental Shuttle Walk Test Predicts Outcome In Pulmonary Hypertension. Thorax, Vol. 69(Suppl 2) (pp A148-A149)
• Stewart N, Norquay G, Parra-Robles J, Marshall H, Leung G, Murphy P, Schulte R, Elliot C, Condliffe R, Billings C , Smith I et al (2014) P273 Assessment Of Lung Microstructure In Interstitial Lung Disease With Hyperpolarised Gas Mri. Thorax, Vol. 69(Suppl 2) (pp A192-A193)
• Billings C, Hurdman J, Condliffe R, Armstrong I, Smith I, Elliot C & Kiely D (2014) S121 The Utility Of The Incremental Shuttle Walking Test In Pulmonary Hypertension: Results From The Aspire Registry. Thorax, Vol. 69(Suppl 2) (pp A65-A65)
• Swift A, Rajaram S, Capener D, Elliot C, Condliffe R, Hurdman J, Kiely D & Wild J (2014) S120 Right Ventricular Dysfunction In Pulmonary Hypertension With Combined Pulmonary Fibrosis And Emphysema Syndrome. Thorax, Vol. 69(Suppl 2) (pp A64-A65)
• Hussain N, Ramjug S, Billings C, Hurdman J, Elliot C, Condliffe R & Kiely D (2014) P168 Reduced Gas Transfer (tlco) Predicts Poor Outcome In Patients With Pulmonary Hypertension And Heart Failure With Preserved Ejection Fraction. Thorax, Vol. 69(Suppl 2) (pp A148-A148)
• De Foneska D, Condliffe R, Elliot C, Hughes R, Hurdman J, Ghafur S, Schofield M, van Veen J, Maclean R & Kiely D (2014) S118 Incidence And Severity Of Chronic Thromboembolic Pulmonary Hypertension Following The Introduction Of A One-stop Clinic For Acute Pulmonary Embolism. Thorax, Vol. 69(Suppl 2) (pp A63-A64)
• Stewart NJ, Leung G, Norquay G, Marshall H, Parra-Robles J, Billings C, Murphy P, Schulte RF, Wolber J, Kiely DG , Whyte MKB et al (2014) Age-dependent changes in whole-lung septal thickness measured by Xe-129 MRI: A comparison of healthy volunteers and subjects with IPF. EUROPEAN RESPIRATORY JOURNAL, Vol. 44
• Sithamparanathan S, Thirugnanasothy L, Nair A, Goghlan G, Elliot C, Fisher A, Gaine S, Gibbs S, Gatzoulis M, Handler C , Howard L et al (2014) Portopulmonary hypertension in United Kingdom; A contemporary, national, observational study. EUROPEAN RESPIRATORY JOURNAL, Vol. 44
• Stewart NJ, Leung G, Norquay G, Marshall H, Parra-Robles J, Billings C, Murphy P, Schulte RF, Wolber J, Kiely DG , Whyte MKB et al (2014) Age-dependent changes in whole-lung septal thickness measured by Xe-129 MRI: A comparison of healthy volunteers and subjects with IPF. EUROPEAN RESPIRATORY JOURNAL, Vol. 44
• Stewart NJ, Leung G, Norquay G, Marshall H, Parra-Robles J, Wolber J, Schulte RF, Condliffe R, Elliot C, Murphy P , Kiely D et al (2014) Dissolved 129xe Mri - Delayed Gas Uptake Indicates Septal Thickening In Patients With Idiopathic Pulmonary Fibrosis And Systemic Sclerosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 189
• Lungu A, Wild J, Swift A, Capener D, Kiely D & Hose DR (2014) Automatic, Simultaneous, Non-invasive Measurements of Flow and Area in the Human Pulmonary Arteries from MRI Images (pp 259-264)
• Rothman AMK, Arnold N, Dawson S, Chang W, Suvarna K, Kiely D, Gunn J & Lawrie A (2014) Radio-Frequency Denervation Of The Pulmonary Artery Reduces Pulmonary Hypertension In An Acute Porcine Model. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 189
• Condliffe R, Elliot CA, Sabroe I, Zamanian RT, Morton A, Swift AJ, Kiely DG & Lawrie A (2013) HEPATOCYTE GROWTH FACTOR CONCENTRATION CORRELATES WITH HAEMODYNAMIC SEVERITY IN CONNECTIVE TISSUE DISEASE-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION. THORAX, Vol. 68 (pp A146-A147)
• Collier G, Swift A, Capener D, Kiely D, Condliffe R, Elliot C & Wild J (2013) Analysis of flow vortices in the pulmonary artery of healthy volunteers and patients with pulmonary hypertension. EUROPEAN RESPIRATORY JOURNAL, Vol. 42
• Hameed AG, Arnold ND, Chamberlain J, Pickworth JA, Paiva C, Dawson S, Cross S, Long L, Zhao L, Morrell NW , Crossman DC et al (2013) Tumour necrosis factor-related apoptosis-inducing ligand is a novel therapeutic target in pulmonary arterial hypertension. The Lancet, Vol. 381, Supplement 1 (pp S47 --S47 -)
• Sproson T, Swift A, Rajaram S, Capener D, Kiely D, Condliffe R, Elliot C & Wild J (2012) MRI assessment of right atrial volume and function in pulmonary hypertension. EUROPEAN RESPIRATORY JOURNAL, Vol. 40
• Swift A, Rajaram S, Capener D, Tom S, Elliot C, Condliffe R, Kiely D & Wild J (2012) Prognostic value of ventricular volumes and function in patients with pulmonary hypertension due to chronic obstructive pulmonary disease. EUROPEAN RESPIRATORY JOURNAL, Vol. 40
• Ling Y, Johnson M, Kiely D, Condliffe R, Elliot C, Gibbs JSR, Howard L, Pepke-Zaba J, Sheares K, Corris P , Fisher A et al (2012) 'Idiopathic' pulmonary arterial hypertension with preserved lung function but co-existing parenchymal abnormalities: Response to treatment and survival. EUROPEAN RESPIRATORY JOURNAL, Vol. 40
• Rajaram S, Swift A, Marshall H, Capener D, Condliffe R, Hurdman J, Elliot C, Wild JM & Kiely DG (2012) Evaluation Of MR Lung Perfusion In The Assessment Of Chronic Thromboembolic Pulmonary Hypertension. C28. DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION
• Hamilton N, Sellars M, Graves M, Billings C, Kiely DG, Hurdman J, Elliot CA, Armstrong IJ & Condliffe R (2012) Ambrisentan For Pulmonary Arterial Hypertension: Clinical Experience Of 101 Patients. C63. MANAGEMENT OF PULMONARY HYPERTENSION
• Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JSR, Howard L, Pepke-Zaba J, Sheares KKK, Corris P , Fisher AJ et al (2012) Prognostic Significance Of Change In Functional Class In Incident Idiopathic Pulmonary Arterial Hypertension. Results From The Pulmonary Hypertension Registry Of The United Kingdom And Ireland. B107. BIOMARKERS AND PREDICTORS OF OUTCOMES IN PULMONARY HYPERTENSION
• Marshall H, Kiely DG, Capener D, Deppe MH, Parra-Robles J, Swift AJ, Rajaram S, Hurdman J, Condliffe R, Wild JM & Elliot CA (2012) Imaging V/Q In Chronic Thromboembolic Pulmonary Hypertension With 3He And 1H MRI. B98. NOVEL APPROACHES TO LUNG IMAGING
• Shepherd AJ, Hopkinson K, Walker SJ, Elliot CA, Condliffe RA, Kiely DG, Pockley G & Lawrie A (2012) Characterising Peripheral Blood Lymphocyte Subpopulations In Clinical And Experimental Pulmonary Hypertension. C28. DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION
• Hurdman J, Condliffe R, Elliot CA, Rajaram S, Swift AJ, Davies C, Hill C, Hamilton N, Armstrong IJ, Billings C , Pollard L et al (2012) Characteristics And Outcomes In Pulmonary Hypertension Associated With COPD/ Emphysema: Results From The ASPIRE Registry. B107. BIOMARKERS AND PREDICTORS OF OUTCOMES IN PULMONARY HYPERTENSION
• Parmar S, Thompson AAR, Higgins KR, Sabroe I, Parker LC, Lawrie A, Arnold J, Walker S, Elliot CA, Condliffe R , Kiely DG et al (2012) Elucidating The Mechanism By Which Monocytes Can Inhibit Hypoxic PA-SMC Proliferation. D33. ASTHMA PATHOGENESIS
• Swift AJ, Rajaram S, Capener D, Hurdman J, Condliffe R, Elliot CA, Wild JM & Kiely DG (2011) MR LV Systolic Eccentricity Index (SEI) Compared To Established Cardiac Mr Parameters For The Diagnosis Of PH: Correlation With Right Heart Catheterization. D26. PULMONARY VASCULAR AND RIGHT HEART PHYSIOLOGY
• Ling Y, Johnson MK, Kiely D, Condliffe R, Elliot C, Gibbs S, Howard L, Pepke-Zaba J, Sheares K, Corris P , Fisher A et al (2011) INFLUENCE OF AGE ON CLINICAL PHENOTYPES OF INCIDENT IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION. RESULTS FROM THE PULMONARY HYPERTENSION REGISTRY OF THE UK AND IRELAND. THORAX, Vol. 66 (pp A34-A35)
• Condliffe R, Pickworth J, Hopkinson K, Hameed A, Walker S, Elliot C, Francis S, Newman C, Crossman D, Morton A , Kiely D et al (2011) SERUM OSTEOPROTEGERIN PREDICTS MORTALITY IN A PROSPECTIVE STUDY ON INCIDENT CASES OF PULMONARY ARTERIAL HYPERTENSION. THORAX, Vol. 66 (pp A34-A34)
• Ling Y, Johnson MK, Kiely D, Condliffe R, Elliot C, Gibbs S, Howard L, Pepke-Zaba J, Sheares K, Corris P , Fisher A et al (2011) PREDICTION OF SURVIVAL IN PULMONARY ARTERIAL HYPERTENSION USING SURVIVAL EQUATIONS. RESULTS FROM THE PULMONARY HYPERTENSION REGISTRY OF THE UK AND IRELAND. THORAX, Vol. 66 (pp A35-A36)
• Swift AJ, Rajaram S, Condliffe R, Capener D, Hill C, Davies C, Hurdman J, Elliot C, Wild JM & Kiely DG (2011) DIAGNOSTIC UTILITY AND PROGNOSTIC VALUE OF QUANTITATIVE CARDIAC MR INDICES IN PATIENTS WITH SUSPECTED PULMONARY HYPERTENSION. THORAX, Vol. 66 (pp A34-A34)
• Rajaram S, Swift AJ, Capener D, Hill C, Davies C, Elliot R, Hurdman J, Condliffe R, Wild JM & Kiely DG (2011) ACCURACY OF CONTRAST ENHANCED MR LUNG PERFUSION COMPARED TO PERFUSION SCINTIGRAPHY IN DIAGNOSING CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION. THORAX, Vol. 66 (pp A13-A14)
• Hurdman J, Condliffe RA, Elliot CA, Sabroe I & Kiely DG (2010) PULMONARY HYPERTENSION (PH) ASSOCIATED WITH LUNG DISEASE/HYPOXIA. THORAX, Vol. 65 (pp A93-A93)
• Shepherd AJ, Hopkinson K, Kiely DG, Elliot CE, Condliffe R, Crossman DC, Pockley AG & Lawrie A (2010) CHARACTERISING T CELL SUB-POPULATIONS IN PULMONARY HYPERTENSION. THORAX, Vol. 65 (pp A91-A91)
• Hickey KP, Gatt A, Sephton P, Kiely DG, Elliot CA, Cooper PC & Makris M (2009) Patients with pulmonary hypertension have higher thrombin generation compared to atrial fibrillation individuals with the same INR. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 7 (pp 1161-1161)
• Condliffe R, Billings C, Elliot CA, Smith I, Armstrong IJ, Smith L & Kiely DG (2008) INCREMENTAL SHUTTLE AND 6-MINUTE WALK TESTS: CORRELATIONS WITH PULMONARY HAEMODYNAMICS AND CARDIOPULMONARY EXERCISE TESTING IN PULMONARY HYPERTENSION. THORAX, Vol. 63 (pp A55-A55)
• Elliot CA, Billings C, Armstrong I, Waterhouse J, Billings C, Akil M & Kiely DG (2007) Reduced incremental shuttle walking test distance is associated with a worse survival in pulmonary arterial hypertension associated with systemic sclerosis. THORAX, Vol. 62 (pp A85-A85)
• Hagger D, Woodhouse N, Elliot CA, Wild J, Armstrong I, Hill C, Davies C & Kiely DG (2007) Ventricular mass index measured using magnetic resonance imaging correlates with pulmonary artery pressure in patients with systemic sclerosis and suspected pulmonary arterial hypertension. THORAX, Vol. 62 (pp A84-A84)
• Wilkinson A, Elliot CA, Mawson S, Armstrong I, Billings C & Kiely DG (2007) A randomised controlled trial to investigate the effects of a physiotherapist-led rehabilitation programme on exercise capacity and quality of life measures in patients with pulmonary hypertension. THORAX, Vol. 62 (pp A16-A17)
• Beghetti M, Hoeper MM, Kiely DG, Carlsen J, Segal E & Humbert M (2006) Long-term safety profile of bosentan in paediatric patients with pulmonary arterial hypertension related to congenital heart defects or other aetiologies. EUROPEAN HEART JOURNAL, Vol. 27 (pp 401-401)
• Denton CP, Coghlan J, Black CM, Hoeper MM, Kiely DG, Carlsen J, Segal E & Humbert M (2006) Long-term safety profile of bosentan in patients with pulmonary arterial hypertension related to mixed connective tissue disease or systemic lupus erythematosus: Results from the Tracleer post marketing surveillance database. ANNALS OF THE RHEUMATIC DISEASES, Vol. 65 (pp 389-389)
• Billings CG, Elliot CA, Armstrong IJ, Saba TS & Kiely DG (2005) Abnormal post-exercise systolic blood pressure response to exercise is common in patients with suspected pulmonary hypertension. THORAX, Vol. 60 (pp II88-II88)
• Kiely DG, Carlsen J, Humbert M, van Lierop C & Hoeper MM (2005) Long term experience with bosentan for the treatment of idiopathic pulmonary arterial hypertension under routine conditions. THORAX, Vol. 60 (pp II88-II89)
• Anwar S, Elliot CA, English K, Williams G, Brooks N, O'Toole L, Armstrong IJ, Hamilton N, Saba TS & Kiely DG (2005) Treatment of pulmonary arterial hypertension in association with systemic to pulmonary shunts: A retrospective review. THORAX, Vol. 60 (pp II89-II89)
• Elliot CA, Wright J, Ryan K, Woodhead M, Armstrong IJ, Saba TS & Kiely DG (2005) Haemolytic disorders complicated by pulmonary hypertension. THORAX, Vol. 60 (pp II87-II88)
• Carlsen J, Humbert M, Kiely DG, van Lierop C, Schwierin B & Hoeper MM (2005) Clinical experience with bosentan for the treatment of pulmonary hypertension associated with congenital heart disease. EUROPEAN HEART JOURNAL, Vol. 26 (pp 215-216)
• Carlsen J, Hoeper MM, Kiely DG, van Lierop C & Humbert M (2005) Long-term safety profile of bosentan in patients with chronic thromboembolic pulmonary hypertension (CTEPH): results from the TRAX database. EUROPEAN HEART JOURNAL, Vol. 26 (pp 113-113)
• Denton CP, Coghlan J, Black CM, Hoeper MM, Kiely DG, Carlsen J, Van Lierop C & Humbert M (2005) Long-term safety profile of bosentan in patients with systemic sclerosis and pulmonary arterial hypertension: Results from the TRAX database. ANNALS OF THE RHEUMATIC DISEASES, Vol. 64 (pp 294-294)
• Elliot CA, Wright J, Ryan K, Woodhead M, Armstrong IJ, Saba TS & Kiely DG (2005) Pulmonary hypertension as a complication of haemolysis. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 129 (pp 47-47)
• Elliot CA, Armstrong IJ, Billings C, Waterhouse J, Hamilton N, Saba T & Kiely DG (2004) Incremental shuttle walking test distance predicts prognosis in patients with pulmonary hypertension treated with targeted pulmonary vascular therapy. THORAX, Vol. 59(1) (pp 85-85)
• Elliot CA, Webster V, Stewart P, Barraclough RM, Mills G, Hutkchinson S, Haworth E, Lawson R, Armstrong IJ & Kiely DG (2004) Use of nebulised iloprost therapy in early pregnancy in patients with pulmonary hypertension. THORAX, Vol. 59(1) (pp 86-86)
• MacDonald IM, Woodhouse N, Elliot C, Armstrong I, Kiely DG, Marshall G & Van Beek EJR (2004) Increased pulmonary artery to aortic ratio measured using magnetic resonance imaging identifies patients with pulmonary hypertension. THORAX, Vol. 59(1) (pp 8-8)
• van Veen J, Elliot CA, Martin L, Armstrong I, Kiely DG, Bowyer AE & Makris M (2004) Elevated factor VIII : C levels in patients with pulmonary hypertension. A marker of endothelial dysfunction?. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 125 (pp 46-46)
• Elliot CA, Armstrong I, Guarasci F, Akil M & Kiely DG (2003) Identification of patients with systemic sclerosis and pulmonary hypertension on exercise using a simple screening protocol. THORAX, Vol. 58 (pp 83-83)
• Elliot CA, Martin L, Armstrong I, Kiely DG, Bowyer AE & Makris M (2003) Elevated factor FVIII: C levels as a marker of endothelial dysfunction in patients with pulmonary hypertension. THORAX, Vol. 58 (pp 9-9)
• Guarasci F, Manuel D, Akil M, Davies C, Fishwick D, Van Beek EJR & Kiely DG (2002) Elevated pulmonary: Aortic ratio in patients with pulmonary arterial hypertension associated with systemic sclerosis. THORAX, Vol. 57
• Siddons T, Higenbottam TW, Guarasci F, Armstrong I, McCormack K & Kiely DG (2002) The haemodynamic effects of "pulsed" inhaled nitric oxide in patients with pulmonary hypertension. THORAX, Vol. 57
• Siddons T, Higenbottam TW, Amsha K, Armstrong I, McCormack K & Kiely DG (2002) Compassionate treatment of pulmonary hypertension with long term inhaled nitric oxide and oral sildenafil (Viagra((R))). THORAX, Vol. 57
• Lee AFC, Kiely DG, Coutie W & Struthers AD (1996) The renin response to frusemide in man is nitric oxide-dependent. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, Vol. 42(5) (pp P652-P652)

Other

• Whitfield AJ, Solanki R, Johns CS, Kiely D, Wild J & Swift AJ (2020) MRI Prediction of Precapillary Pulmonary Hypertension according to the Sixth World Symposium on Pulmonary Hypertension. Radiology, 294(2), 482-482. View this article in WRRO
• Farmery JHR, Smith ML & Lynch AG (2018) Publisher Correction: Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data. Scientific Reports, 8(1).
• Swift AJ, Wild JM & Kiely DG (2018) Reply to Hou et al.: Can Magnetic Resonance Imaging Effectively Evaluate the Prognosis of Patients with Pulmonary Arterial Hypertension?. American Journal of Respiratory and Critical Care Medicine, 197(5), 676-677.
• Rajaram S, Swift AJ, Wild JM & Kiely DG (2015) Response to: ‘CT assessment for pulmonary hypertension requires systematic assessment of cardiac, vascular and parenchymal signs’ by Marloeset al. Thorax, 70(11), 1087.2-1088.
• Rajaram S, Swift AJ, Telfer A, Hurdman J, Marshall H, Lorenz E, Capener D, Davies C, Hill C, Elliot C , Condliffe R et al (2013) 3D contrast-enhanced lung perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry.. Thorax, 68(7), 677-678.

Preprints

• Varian F, Dick J, Battersby C, Roman S, Ablott J, Watson L, Binmahfooz S, Zafar H, Colgan G, Cannon J , Suntharalingam J et al (2023) Pulmonary Hypertension: Intensification and Personalisation of Combination Rx (PHoenix): A phase IV randomised trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologies, Cold Spring Harbor Laboratory.
• Middleton JT, Binmahfooz S, Zafar H, Patel J, Ashraf C, Taylor J, Neelam-Naganathan D, Battersby C, Pearson C, Roddis C , Roman S et al (2023) Remote evaluation of risk and physiological response to therapeutic escalation and clinical worsening in patients with pulmonary hypertension, Cold Spring Harbor Laboratory.
• Prapa M, Lago-Docampo M, Swietlik EM, Montani D, Eyries M, Humbert M, Welch CCL, Chung W, Berger RMF, Bogaard HJ , Danhaive O et al (2022) First genotype-phenotype study in TBX4 syndrome: gain-of-function mutations causative for lung disease, Cold Spring Harbor Laboratory.
• Swietlik EM, Greene D, Zhu N, Megy K, Cogliano M, Rajaram S, Pandya D, Tilly T, Lutz KA, Welch CCL , Pauciulo MW et al (2019) Bayesian inference associates rare KDR variants with specific phenotypes in pulmonary arterial hypertension, Cold Spring Harbor Laboratory.
• Rhodes CJ, Batai K, Bleda M, Haimel M, Southgate L, Germain M, Pauciulo MW, Hadinnapola C, Aman J, Girerd B , Arora A et al (2018) Genetic determinants of risk and survival in pulmonary arterial hypertension, Cold Spring Harbor Laboratory.
• Gräf S, Haimel M, Bleda M, Hadinnapola C, Southgate L, Li W, Hodgson J, Liu B, Salmon RM, Southwood M , Machado RD et al (2017) Identification of novel rare sequence variation underlying heritable pulmonary arterial hypertension, Cold Spring Harbor Laboratory.
• Jones R, De Bie E, Groves E, Zalewska KI, Swietlik EM, Treacy C, Martin J, Polwarth G, Guo J, Baxendale H , Coleman S et al () Autoimmunity is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension.